activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2147233	CHEMBL922808	Activity of human DAPK1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	114.0	CHEMBL2558	Homo sapiens	Activity	%	114.0
	2147233	CHEMBL922808	Activity of human DAPK1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	114.0	CHEMBL2558	Homo sapiens	Activity	%	114.0
	2279706	CHEMBL960114	Inhibition of DAPK1	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Ki	nM	10000.0	CHEMBL2558	Homo sapiens	Ki	uM	10.0
	2470144	CHEMBL1034093	Inhibition of DAPK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2558	Homo sapiens	INH	%	10.0
	2511573	CHEMBL972532	Inhibition of DAPK1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.5	CHEMBL2558	Homo sapiens	IC50	uM	0.0005
	2567233	CHEMBL973716	Inhibition of human DAPK1 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	107.0	CHEMBL2558	Homo sapiens	Activity	%	107.0
	2704627	CHEMBL1054862	Inhibition of DAPK1 at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	-1.17	CHEMBL2558	Homo sapiens	INH	%	-1.17
	2721584	CHEMBL1060992	Inhibition of DAPK1 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	2902446	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902447	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902448	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902449	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902450	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902451	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902452	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902453	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902454	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902455	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902456	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902457	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902458	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902459	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902460	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902461	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902462	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902463	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902464	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902465	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902466	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902467	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	970.0	CHEMBL2558	Homo sapiens	Kd	nM	970.0
	2902468	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902469	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902470	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	2400.0	CHEMBL2558	Homo sapiens	Kd	nM	2400.0
	2902471	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	4700.0	CHEMBL2558	Homo sapiens	Kd	nM	4700.0
	2902472	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902473	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902474	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902475	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902476	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902477	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902478	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.4	CHEMBL2558	Homo sapiens	Kd	nM	1.4
	2902479	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	270.0	CHEMBL2558	Homo sapiens	Kd	nM	270.0
	2902480	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	120.0	CHEMBL2558	Homo sapiens	Kd	nM	120.0
	2902481	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902482	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2902483	CHEMBL1044652	Binding constant for DAPK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	2921384	CHEMBL1055284	Inhibition of DAPK1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	90.0	CHEMBL2558	Homo sapiens	Activity	%	90.0
	2938515	CHEMBL1041350	Inhibition of DAPK1 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	2.0	CHEMBL2558	Homo sapiens	INH	%	2.0
	2938627	CHEMBL1041497	Inhibition of DAPK1	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	<	IC50	nM	1000.0	CHEMBL2558	Homo sapiens	IC50	microM	1.0
	3052576	CHEMBL1037117	Residual activity of DAPK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL2558	Homo sapiens	Residual activity	%	90.0
	3053885	CHEMBL1044285	Residual activity of DAPK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	15.0	CHEMBL2558	Homo sapiens	Residual activity	%	15.0
	3054137	CHEMBL1040241	Residual activity of DAPK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	73.0	CHEMBL2558	Homo sapiens	Residual activity	%	73.0
	3055424	CHEMBL1037117	Residual activity of DAPK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	81.0	CHEMBL2558	Homo sapiens	Residual activity	%	81.0
	3055676	CHEMBL1044285	Residual activity of DAPK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	24.0	CHEMBL2558	Homo sapiens	Residual activity	%	24.0
	3056981	CHEMBL1040241	Residual activity of DAPK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	86.0	CHEMBL2558	Homo sapiens	Residual activity	%	86.0
	3058301	CHEMBL1037117	Residual activity of DAPK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	86.0	CHEMBL2558	Homo sapiens	Residual activity	%	86.0
	3058553	CHEMBL1044285	Residual activity of DAPK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	25.0	CHEMBL2558	Homo sapiens	Residual activity	%	25.0
	3072899	CHEMBL1040241	Residual activity of DAPK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	80.0	CHEMBL2558	Homo sapiens	Residual activity	%	80.0
	3130823	CHEMBL1073716	Inhibition of DAPK1 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3213914	CHEMBL1114870	Inhibition of DAPK1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	1.0	CHEMBL2558	Homo sapiens	INH	%	1.0
	3224764	CHEMBL1102579	Inhibition of DAPK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3224987	CHEMBL1102579	Inhibition of DAPK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3261140	CHEMBL1112576	Inhibition of DAPK1 at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	98.0	CHEMBL2558	Homo sapiens	INH	%	98.0
	3261141	CHEMBL1112576	Inhibition of DAPK1 at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786	=	Inhibition	%	98.0	CHEMBL2558	Homo sapiens	INH	%	98.0
	3261142	CHEMBL1112576	Inhibition of DAPK1 at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787	=	Inhibition	%	76.0	CHEMBL2558	Homo sapiens	INH	%	76.0
	3261143	CHEMBL1112576	Inhibition of DAPK1 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	91.0	CHEMBL2558	Homo sapiens	INH	%	91.0
	3261144	CHEMBL1112576	Inhibition of DAPK1 at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764	=	Inhibition	%	97.0	CHEMBL2558	Homo sapiens	INH	%	97.0
	3261145	CHEMBL1112576	Inhibition of DAPK1 at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	82.0	CHEMBL2558	Homo sapiens	INH	%	82.0
	3331888	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3333303	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3334708	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3336128	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3337494	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3337743	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3339075	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3340377	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3340656	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3342072	CHEMBL1168847	Inhibition of DAPK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	3358521	CHEMBL1174309	Inhibition of DAPK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL2558	Homo sapiens	INH	%	100.0
	3358963	CHEMBL1174309	Inhibition of DAPK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	94.0	CHEMBL2558	Homo sapiens	INH	%	94.0
	3445076	CHEMBL1244785	Binding affinity to DAPK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	80.0	CHEMBL2558	Homo sapiens	Kd	nM	80.0
	3448393	CHEMBL1244785	Binding affinity to DAPK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	3448902	CHEMBL1244785	Binding affinity to DAPK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	4700.0	CHEMBL2558	Homo sapiens	Kd	nM	4700.0
	3449146	CHEMBL1244785	Binding affinity to DAPK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	120.0	CHEMBL2558	Homo sapiens	Kd	nM	120.0
	3449620	CHEMBL1244785	Binding affinity to DAPK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	3450042	CHEMBL1244785	Binding affinity to DAPK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	3450961	CHEMBL1244785	Binding affinity to DAPK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	3601431	CHEMBL1292405	Inhibition of DAPK1	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	>	IC50	nM	30000.0	CHEMBL2558	Homo sapiens	IC50	uM	30.0
	5120401	CHEMBL1648383	Inhibition of human DAPK1 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	108.0	CHEMBL2558	Homo sapiens	INH	%	108.0
Not Active	6153744	CHEMBL1764729	Binding affinity to DAPK1 at 10 uM by radioligand binding assay	B	CNc1nn2c(C)cc(C)nc2c1S(=O)(=O)c1ccccc1		CHEMBL1668584		Activity			CHEMBL2558	Homo sapiens	Activity		
	6340931	CHEMBL1826955	Activity of DAPK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	92.0	CHEMBL2558	Homo sapiens	Activity	%	92.0
	7567369	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7567828	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7568325	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7568757	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	270.0	CHEMBL2558	Homo sapiens	Kd	nM	270.0
	7569342	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7569832	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7570295	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7570722	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	120.0	CHEMBL2558	Homo sapiens	Kd	nM	120.0
	7571333	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7571809	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	72.0	CHEMBL2558	Homo sapiens	Kd	nM	72.0
	7572272	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	2400.0	CHEMBL2558	Homo sapiens	Kd	nM	2400.0
	7572688	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1800.0	CHEMBL2558	Homo sapiens	Kd	nM	1800.0
	7572857	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	540.0	CHEMBL2558	Homo sapiens	Kd	nM	540.0
	7573314	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7573790	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	5000.0	CHEMBL2558	Homo sapiens	Kd	nM	5000.0
	7574259	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	4700.0	CHEMBL2558	Homo sapiens	Kd	nM	4700.0
	7574667	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7574835	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7575296	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7575767	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7576232	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7576640	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	16.0	CHEMBL2558	Homo sapiens	Kd	nM	16.0
	7576809	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7577268	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7577746	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	360.0	CHEMBL2558	Homo sapiens	Kd	nM	360.0
	7578216	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	97.0	CHEMBL2558	Homo sapiens	Kd	nM	97.0
	7578817	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	1600.0	CHEMBL2558	Homo sapiens	Kd	nM	1600.0
	7579191	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7579641	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7580115	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7580545	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7581175	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7581560	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7582005	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7582498	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7582898	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7583521	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7583918	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7584392	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7584854	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	55.0	CHEMBL2558	Homo sapiens	Kd	nM	55.0
	7585258	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7585851	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7586259	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7586263	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	4000.0	CHEMBL2558	Homo sapiens	Kd	nM	4000.0
	7586734	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	970.0	CHEMBL2558	Homo sapiens	Kd	nM	970.0
	7587188	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7588242	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7588713	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7589164	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7589335	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7589759	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	80.0	CHEMBL2558	Homo sapiens	Kd	nM	80.0
	7590226	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	620.0	CHEMBL2558	Homo sapiens	Kd	nM	620.0
	7590700	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7591151	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7591308	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7591730	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7592202	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	1400.0	CHEMBL2558	Homo sapiens	Kd	nM	1400.0
	7592675	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7593128	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7593275	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7593710	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7594182	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	3000.0	CHEMBL2558	Homo sapiens	Kd	nM	3000.0
	7594655	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7595243	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7595687	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7596161	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7596637	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7597215	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7597668	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7598141	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7598169	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	nM	10000.0
	7598611	CHEMBL1908668	Binding constant for DAPK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.4	CHEMBL2558	Homo sapiens	Kd	nM	1.4
	7959727	CHEMBL1932838	Inhibition of DAPK1	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL2558	Homo sapiens	IC50	uM	30.0
	7959728	CHEMBL1932838	Inhibition of DAPK1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL2558	Homo sapiens	IC50	uM	30.0
	7969708	CHEMBL1930964	Inhibition of DAPK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	101.0	CHEMBL2558	Homo sapiens	Activity	%	101.0
Active	7996784	CHEMBL1941720	Inhibition of DAPK1 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	7996785	CHEMBL1941720	Inhibition of DAPK1 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	7996786	CHEMBL1941720	Inhibition of DAPK1 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	7996787	CHEMBL1941720	Inhibition of DAPK1 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
	8061263	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.81	CHEMBL2558	Homo sapiens	Inhibition	%	0.81
	8061440	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.68	CHEMBL2558	Homo sapiens	Inhibition	%	-3.68
	8061771	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.54	CHEMBL2558	Homo sapiens	Inhibition	%	2.54
	8061962	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.44	CHEMBL2558	Homo sapiens	Inhibition	%	2.44
	8062186	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	7.28	CHEMBL2558	Homo sapiens	Inhibition	%	7.28
	8062302	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.36	CHEMBL2558	Homo sapiens	Inhibition	%	2.36
	8062688	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.75	CHEMBL2558	Homo sapiens	Inhibition	%	5.75
	8062786	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.7	CHEMBL2558	Homo sapiens	Inhibition	%	2.7
	8063010	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.93	CHEMBL2558	Homo sapiens	Inhibition	%	0.93
	8063142	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.16	CHEMBL2558	Homo sapiens	Inhibition	%	1.16
	8063309	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.96	CHEMBL2558	Homo sapiens	Inhibition	%	1.96
	8063533	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.18	CHEMBL2558	Homo sapiens	Inhibition	%	2.18
	8063641	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.4	CHEMBL2558	Homo sapiens	Inhibition	%	2.4
	8064047	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.28	CHEMBL2558	Homo sapiens	Inhibition	%	2.28
	8064162	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.42	CHEMBL2558	Homo sapiens	Inhibition	%	2.42
	8064386	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.42	CHEMBL2558	Homo sapiens	Inhibition	%	1.42
	8064596	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.85	CHEMBL2558	Homo sapiens	Inhibition	%	1.85
	8064734	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.44	CHEMBL2558	Homo sapiens	Inhibition	%	1.44
	8065124	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.58	CHEMBL2558	Homo sapiens	Inhibition	%	2.58
	8065240	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.62	CHEMBL2558	Homo sapiens	Inhibition	%	2.62
	8065464	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.43	CHEMBL2558	Homo sapiens	Inhibition	%	2.43
	8065639	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.46	CHEMBL2558	Homo sapiens	Inhibition	%	4.46
	8065978	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.59	CHEMBL2558	Homo sapiens	Inhibition	%	0.59
	8066188	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.87	CHEMBL2558	Homo sapiens	Inhibition	%	0.87
	8066324	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.47	CHEMBL2558	Homo sapiens	Inhibition	%	1.47
	8066548	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.9	CHEMBL2558	Homo sapiens	Inhibition	%	1.9
	8066714	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.76	CHEMBL2558	Homo sapiens	Inhibition	%	3.76
	8067062	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.38	CHEMBL2558	Homo sapiens	Inhibition	%	2.38
	8067237	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.73	CHEMBL2558	Homo sapiens	Inhibition	%	3.73
	8067582	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.72	CHEMBL2558	Homo sapiens	Inhibition	%	0.72
	8067792	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.17	CHEMBL2558	Homo sapiens	Inhibition	%	2.17
	8068151	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.26	CHEMBL2558	Homo sapiens	Inhibition	%	1.26
	8068315	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.18	CHEMBL2558	Homo sapiens	Inhibition	%	2.18
	8068664	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.39	CHEMBL2558	Homo sapiens	Inhibition	%	0.39
	8068838	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.43	CHEMBL2558	Homo sapiens	Inhibition	%	5.43
	8069062	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.27	CHEMBL2558	Homo sapiens	Inhibition	%	3.27
	8069187	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.99	CHEMBL2558	Homo sapiens	Inhibition	%	0.99
	8069482	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	1.6	CHEMBL2558	Homo sapiens	Inhibition	%	1.6
	8069643	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.82	CHEMBL2558	Homo sapiens	Inhibition	%	2.82
	8069867	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.88	CHEMBL2558	Homo sapiens	Inhibition	%	2.88
	8069993	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.36	CHEMBL2558	Homo sapiens	Inhibition	%	0.36
	8070389	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.63	CHEMBL2558	Homo sapiens	Inhibition	%	4.63
	8070514	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.1	CHEMBL2558	Homo sapiens	Inhibition	%	0.1
	8070812	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	1.71	CHEMBL2558	Homo sapiens	Inhibition	%	1.71
	8071193	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.49	CHEMBL2558	Homo sapiens	Inhibition	%	3.49
	8071319	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.65	CHEMBL2558	Homo sapiens	Inhibition	%	0.65
	8071543	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.85	CHEMBL2558	Homo sapiens	Inhibition	%	0.85
	8071716	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.14	CHEMBL2558	Homo sapiens	Inhibition	%	3.14
	8071841	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.6	CHEMBL2558	Homo sapiens	Inhibition	%	-0.6
	8072065	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.48	CHEMBL2558	Homo sapiens	Inhibition	%	-0.48
	8072155	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.43	CHEMBL2558	Homo sapiens	Inhibition	%	0.43
	8072379	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.6	CHEMBL2558	Homo sapiens	Inhibition	%	-0.6
	8072536	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.21	CHEMBL2558	Homo sapiens	Inhibition	%	3.21
	8072885	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.75	CHEMBL2558	Homo sapiens	Inhibition	%	-0.75
	8073052	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.49	CHEMBL2558	Homo sapiens	Inhibition	%	4.49
	8073401	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-1.22	CHEMBL2558	Homo sapiens	Inhibition	%	-1.22
	8073520	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.46	CHEMBL2558	Homo sapiens	Inhibition	%	0.46
	8073744	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.29	CHEMBL2558	Homo sapiens	Inhibition	%	1.29
	8073977	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.05	CHEMBL2558	Homo sapiens	Inhibition	%	0.05
	8074129	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.19	CHEMBL2558	Homo sapiens	Inhibition	%	3.19
	8074483	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.63	CHEMBL2558	Homo sapiens	Inhibition	%	-1.63
	8074640	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.51	CHEMBL2558	Homo sapiens	Inhibition	%	2.51
	8074991	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.26	CHEMBL2558	Homo sapiens	Inhibition	%	-1.26
	8075326	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.52	CHEMBL2558	Homo sapiens	Inhibition	%	0.52
	8075563	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.31	CHEMBL2558	Homo sapiens	Inhibition	%	-0.31
	8075704	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.48	CHEMBL2558	Homo sapiens	Inhibition	%	3.48
	8075928	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.41	CHEMBL2558	Homo sapiens	Inhibition	%	3.41
	8076070	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.67	CHEMBL2558	Homo sapiens	Inhibition	%	-0.67
	8076218	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.92	CHEMBL2558	Homo sapiens	Inhibition	%	4.92
	8076442	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.25	CHEMBL2558	Homo sapiens	Inhibition	%	2.25
	8076576	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.59	CHEMBL2558	Homo sapiens	Inhibition	%	-1.59
	8076902	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.3	CHEMBL2558	Homo sapiens	Inhibition	%	2.3
	8077149	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.91	CHEMBL2558	Homo sapiens	Inhibition	%	-0.91
	8077501	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.42	CHEMBL2558	Homo sapiens	Inhibition	%	3.42
	8077652	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-2.31	CHEMBL2558	Homo sapiens	Inhibition	%	-2.31
	8078019	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.51	CHEMBL2558	Homo sapiens	Inhibition	%	1.51
	8078158	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.1	CHEMBL2558	Homo sapiens	Inhibition	%	-2.1
	8078484	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.46	CHEMBL2558	Homo sapiens	Inhibition	%	0.46
	8078734	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	2.31	CHEMBL2558	Homo sapiens	Inhibition	%	2.31
	8079074	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.66	CHEMBL2558	Homo sapiens	Inhibition	%	2.66
	8079232	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.62	CHEMBL2558	Homo sapiens	Inhibition	%	-1.62
	8079456	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-5.26	CHEMBL2558	Homo sapiens	Inhibition	%	-5.26
	8079598	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.43	CHEMBL2558	Homo sapiens	Inhibition	%	2.43
	8079737	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-3.49	CHEMBL2558	Homo sapiens	Inhibition	%	-3.49
	8079961	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.52	CHEMBL2558	Homo sapiens	Inhibition	%	3.52
	8080066	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.92	CHEMBL2558	Homo sapiens	Inhibition	%	1.92
	8080318	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-2.01	CHEMBL2558	Homo sapiens	Inhibition	%	-2.01
	8080542	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	3.08	CHEMBL2558	Homo sapiens	Inhibition	%	3.08
	8080657	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.34	CHEMBL2558	Homo sapiens	Inhibition	%	3.34
	8081045	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.18	CHEMBL2558	Homo sapiens	Inhibition	%	-2.18
	8081180	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.11	CHEMBL2558	Homo sapiens	Inhibition	%	3.11
	8081548	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	49.98	CHEMBL2558	Homo sapiens	Inhibition	%	49.98
	8081651	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.29	CHEMBL2558	Homo sapiens	Inhibition	%	1.29
	8081875	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.13	CHEMBL2558	Homo sapiens	Inhibition	%	2.13
	8082127	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.34	CHEMBL2558	Homo sapiens	Inhibition	%	-1.34
	8082240	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.26	CHEMBL2558	Homo sapiens	Inhibition	%	3.26
	8082637	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.07	CHEMBL2558	Homo sapiens	Inhibition	%	-3.07
	8082760	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.9	CHEMBL2558	Homo sapiens	Inhibition	%	2.9
	8082984	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.36	CHEMBL2558	Homo sapiens	Inhibition	%	4.36
	8083140	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	11.11	CHEMBL2558	Homo sapiens	Inhibition	%	11.11
	8083463	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.43	CHEMBL2558	Homo sapiens	Inhibition	%	1.43
	8083717	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.97	CHEMBL2558	Homo sapiens	Inhibition	%	-1.97
	8083827	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.13	CHEMBL2558	Homo sapiens	Inhibition	%	2.13
	8084051	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.09	CHEMBL2558	Homo sapiens	Inhibition	%	2.09
	8084236	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	10.95	CHEMBL2558	Homo sapiens	Inhibition	%	10.95
	8084578	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.91	CHEMBL2558	Homo sapiens	Inhibition	%	2.91
	8084739	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	14.16	CHEMBL2558	Homo sapiens	Inhibition	%	14.16
	8085061	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.29	CHEMBL2558	Homo sapiens	Inhibition	%	3.29
	8085317	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.06	CHEMBL2558	Homo sapiens	Inhibition	%	-3.06
	8085649	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.63	CHEMBL2558	Homo sapiens	Inhibition	%	2.63
	8085838	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	63.0	CHEMBL2558	Homo sapiens	Inhibition	%	63.0
	8086177	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.0	CHEMBL2558	Homo sapiens	Inhibition	%	4.0
	8086339	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.41	CHEMBL2558	Homo sapiens	Inhibition	%	2.41
	8086563	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.5	CHEMBL2558	Homo sapiens	Inhibition	%	2.5
	8086662	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.08	CHEMBL2558	Homo sapiens	Inhibition	%	1.08
	8086873	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.23	CHEMBL2558	Homo sapiens	Inhibition	%	2.23
	8087097	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.5	CHEMBL2558	Homo sapiens	Inhibition	%	0.5
	8087255	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.61	CHEMBL2558	Homo sapiens	Inhibition	%	-0.61
	8087593	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-1.69	CHEMBL2558	Homo sapiens	Inhibition	%	-1.69
	8087731	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	8.26	CHEMBL2558	Homo sapiens	Inhibition	%	8.26
	8087955	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.62	CHEMBL2558	Homo sapiens	Inhibition	%	-0.62
	8088097	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	8.15	CHEMBL2558	Homo sapiens	Inhibition	%	8.15
	8088245	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.28	CHEMBL2558	Homo sapiens	Inhibition	%	2.28
	8088469	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.38	CHEMBL2558	Homo sapiens	Inhibition	%	1.38
	8088597	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	13.51	CHEMBL2558	Homo sapiens	Inhibition	%	13.51
	8088914	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	7.32	CHEMBL2558	Homo sapiens	Inhibition	%	7.32
	8089266	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	16.78	CHEMBL2558	Homo sapiens	Inhibition	%	16.78
	8089414	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	9.26	CHEMBL2558	Homo sapiens	Inhibition	%	9.26
	8089758	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.59	CHEMBL2558	Homo sapiens	Inhibition	%	4.59
	8089938	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.3	CHEMBL2558	Homo sapiens	Inhibition	%	1.3
	8090327	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.15	CHEMBL2558	Homo sapiens	Inhibition	%	5.15
	8090494	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.5	CHEMBL2558	Homo sapiens	Inhibition	%	3.5
	8090857	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.79	CHEMBL2558	Homo sapiens	Inhibition	%	3.79
	8091062	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.08	CHEMBL2558	Homo sapiens	Inhibition	%	3.08
	8091423	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.81	CHEMBL2558	Homo sapiens	Inhibition	%	6.81
	8091578	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-3.18	CHEMBL2558	Homo sapiens	Inhibition	%	-3.18
	8091918	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-4.43	CHEMBL2558	Homo sapiens	Inhibition	%	-4.43
	8092279	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.87	CHEMBL2558	Homo sapiens	Inhibition	%	-1.87
	8092430	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.74	CHEMBL2558	Homo sapiens	Inhibition	%	2.74
	8092802	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-9.21	CHEMBL2558	Homo sapiens	Inhibition	%	-9.21
	8092931	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	8.9	CHEMBL2558	Homo sapiens	Inhibition	%	8.9
	8093243	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-0.68	CHEMBL2558	Homo sapiens	Inhibition	%	-0.68
	8093607	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-8.66	CHEMBL2558	Homo sapiens	Inhibition	%	-8.66
	8093746	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	10.17	CHEMBL2558	Homo sapiens	Inhibition	%	10.17
	8094090	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.97	CHEMBL2558	Homo sapiens	Inhibition	%	4.97
	8094270	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.92	CHEMBL2558	Homo sapiens	Inhibition	%	1.92
	8094494	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.04	CHEMBL2558	Homo sapiens	Inhibition	%	0.04
	8094669	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	5.07	CHEMBL2558	Homo sapiens	Inhibition	%	5.07
	8094825	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.62	CHEMBL2558	Homo sapiens	Inhibition	%	1.62
	8095049	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.7	CHEMBL2558	Homo sapiens	Inhibition	%	2.7
	8095189	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.02	CHEMBL2558	Homo sapiens	Inhibition	%	2.02
	8095392	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.36	CHEMBL2558	Homo sapiens	Inhibition	%	1.36
	8095757	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.22	CHEMBL2558	Homo sapiens	Inhibition	%	6.22
	8095905	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	9.32	CHEMBL2558	Homo sapiens	Inhibition	%	9.32
	8096129	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	8.23	CHEMBL2558	Homo sapiens	Inhibition	%	8.23
	8096246	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	8.37	CHEMBL2558	Homo sapiens	Inhibition	%	8.37
	8096609	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.85	CHEMBL2558	Homo sapiens	Inhibition	%	1.85
	8096765	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.04	CHEMBL2558	Homo sapiens	Inhibition	%	-0.04
	8097136	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-9.5	CHEMBL2558	Homo sapiens	Inhibition	%	-9.5
	8097443	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.04	CHEMBL2558	Homo sapiens	Inhibition	%	1.04
	8097667	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	9.18	CHEMBL2558	Homo sapiens	Inhibition	%	9.18
	8097817	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-7.69	CHEMBL2558	Homo sapiens	Inhibition	%	-7.69
	8097950	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.22	CHEMBL2558	Homo sapiens	Inhibition	%	1.22
	8098174	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.01	CHEMBL2558	Homo sapiens	Inhibition	%	0.01
	8098294	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.92	CHEMBL2558	Homo sapiens	Inhibition	%	1.92
	8098698	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.45	CHEMBL2558	Homo sapiens	Inhibition	%	2.45
	8098883	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	46.02	CHEMBL2558	Homo sapiens	Inhibition	%	46.02
	8099251	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.73	CHEMBL2558	Homo sapiens	Inhibition	%	1.73
	8099393	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.16	CHEMBL2558	Homo sapiens	Inhibition	%	4.16
	8099587	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.33	CHEMBL2558	Homo sapiens	Inhibition	%	1.33
	8099811	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.06	CHEMBL2558	Homo sapiens	Inhibition	%	0.06
	8099958	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-3.26	CHEMBL2558	Homo sapiens	Inhibition	%	-3.26
	8100328	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-1.79	CHEMBL2558	Homo sapiens	Inhibition	%	-1.79
	8100444	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	7.45	CHEMBL2558	Homo sapiens	Inhibition	%	7.45
	8100668	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.55	CHEMBL2558	Homo sapiens	Inhibition	%	2.55
	8100808	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.97	CHEMBL2558	Homo sapiens	Inhibition	%	0.97
	8100968	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	13.98	CHEMBL2558	Homo sapiens	Inhibition	%	13.98
	8101192	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	12.18	CHEMBL2558	Homo sapiens	Inhibition	%	12.18
	8101334	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.78	CHEMBL2558	Homo sapiens	Inhibition	%	1.78
	8101519	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.77	CHEMBL2558	Homo sapiens	Inhibition	%	3.77
	8101743	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.29	CHEMBL2558	Homo sapiens	Inhibition	%	1.29
	8101996	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	11.17	CHEMBL2558	Homo sapiens	Inhibition	%	11.17
	8102151	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.17	CHEMBL2558	Homo sapiens	Inhibition	%	0.17
	8102506	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.0	CHEMBL2558	Homo sapiens	Inhibition	%	4.0
	8102626	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.02	CHEMBL2558	Homo sapiens	Inhibition	%	1.02
	8102850	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.61	CHEMBL2558	Homo sapiens	Inhibition	%	1.61
	8103028	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.73	CHEMBL2558	Homo sapiens	Inhibition	%	0.73
	8103224	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.88	CHEMBL2558	Homo sapiens	Inhibition	%	2.88
	8103586	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.65	CHEMBL2558	Homo sapiens	Inhibition	%	0.65
	8103736	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.98	CHEMBL2558	Homo sapiens	Inhibition	%	1.98
	8103960	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.53	CHEMBL2558	Homo sapiens	Inhibition	%	5.53
	8104145	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.42	CHEMBL2558	Homo sapiens	Inhibition	%	0.42
	8104293	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-4.37	CHEMBL2558	Homo sapiens	Inhibition	%	-4.37
	8104517	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	7.7	CHEMBL2558	Homo sapiens	Inhibition	%	7.7
	8104663	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-3.71	CHEMBL2558	Homo sapiens	Inhibition	%	-3.71
	8105001	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.22	CHEMBL2558	Homo sapiens	Inhibition	%	-0.22
	8105141	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-8.78	CHEMBL2558	Homo sapiens	Inhibition	%	-8.78
	8105531	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.53	CHEMBL2558	Homo sapiens	Inhibition	%	3.53
	8105669	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.28	CHEMBL2558	Homo sapiens	Inhibition	%	1.28
	8105893	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.51	CHEMBL2558	Homo sapiens	Inhibition	%	2.51
	8105949	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-6.34	CHEMBL2558	Homo sapiens	Inhibition	%	-6.34
	8106173	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-5.4	CHEMBL2558	Homo sapiens	Inhibition	%	-5.4
	8106338	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.55	CHEMBL2558	Homo sapiens	Inhibition	%	0.55
	8106494	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.2	CHEMBL2558	Homo sapiens	Inhibition	%	0.2
	8106718	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.99	CHEMBL2558	Homo sapiens	Inhibition	%	-2.99
	8106847	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.29	CHEMBL2558	Homo sapiens	Inhibition	%	4.29
	8107192	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.12	CHEMBL2558	Homo sapiens	Inhibition	%	1.12
	8107364	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.27	CHEMBL2558	Homo sapiens	Inhibition	%	1.27
	8107565	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.82	CHEMBL2558	Homo sapiens	Inhibition	%	4.82
	8107789	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.26	CHEMBL2558	Homo sapiens	Inhibition	%	5.26
	8107924	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-2.63	CHEMBL2558	Homo sapiens	Inhibition	%	-2.63
	8108306	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.0	CHEMBL2558	Homo sapiens	Inhibition	%	3.0
	8108481	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.2	CHEMBL2558	Homo sapiens	Inhibition	%	-0.2
	8108852	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	9.2	CHEMBL2558	Homo sapiens	Inhibition	%	9.2
	8108994	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.67	CHEMBL2558	Homo sapiens	Inhibition	%	1.67
	8109332	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	12.58	CHEMBL2558	Homo sapiens	Inhibition	%	12.58
	8109462	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1	Outside typical range	CHEMBL275168	=	Inhibition	%	-10.38	CHEMBL2558	Homo sapiens	Inhibition	%	-10.38
	8109686	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.92	CHEMBL2558	Homo sapiens	Inhibition	%	0.92
	8109857	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.99	CHEMBL2558	Homo sapiens	Inhibition	%	1.99
	8110213	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-0.73	CHEMBL2558	Homo sapiens	Inhibition	%	-0.73
	8110492	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.76	CHEMBL2558	Homo sapiens	Inhibition	%	3.76
	8110658	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.77	CHEMBL2558	Homo sapiens	Inhibition	%	0.77
	8111040	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-3.38	CHEMBL2558	Homo sapiens	Inhibition	%	-3.38
	8111163	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-5.09	CHEMBL2558	Homo sapiens	Inhibition	%	-5.09
	8111514	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.35	CHEMBL2558	Homo sapiens	Inhibition	%	1.35
	8111680	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.0	CHEMBL2558	Homo sapiens	Inhibition	%	0.0
	8111904	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.17	CHEMBL2558	Homo sapiens	Inhibition	%	-0.17
	8112109	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.39	CHEMBL2558	Homo sapiens	Inhibition	%	3.39
	8112246	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.32	CHEMBL2558	Homo sapiens	Inhibition	%	0.32
	8112638	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	5.41	CHEMBL2558	Homo sapiens	Inhibition	%	5.41
	8112810	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.21	CHEMBL2558	Homo sapiens	Inhibition	%	-0.21
	8113186	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.77	CHEMBL2558	Homo sapiens	Inhibition	%	1.77
	8113322	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.71	CHEMBL2558	Homo sapiens	Inhibition	%	0.71
	8113546	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-9.06	CHEMBL2558	Homo sapiens	Inhibition	%	-9.06
	8113670	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	11.5	CHEMBL2558	Homo sapiens	Inhibition	%	11.5
	8114010	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.27	CHEMBL2558	Homo sapiens	Inhibition	%	1.27
	8114186	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.71	CHEMBL2558	Homo sapiens	Inhibition	%	6.71
	8114542	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	13.25	CHEMBL2558	Homo sapiens	Inhibition	%	13.25
	8114818	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.32	CHEMBL2558	Homo sapiens	Inhibition	%	5.32
	8114984	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.18	CHEMBL2558	Homo sapiens	Inhibition	%	3.18
	8115373	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	7.49	CHEMBL2558	Homo sapiens	Inhibition	%	7.49
	8115493	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-5.23	CHEMBL2558	Homo sapiens	Inhibition	%	-5.23
	8115717	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	4.88	CHEMBL2558	Homo sapiens	Inhibition	%	4.88
	8115850	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.89	CHEMBL2558	Homo sapiens	Inhibition	%	0.89
	8116233	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.07	CHEMBL2558	Homo sapiens	Inhibition	%	0.07
	8116436	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.3	CHEMBL2558	Homo sapiens	Inhibition	%	4.3
	8116570	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.72	CHEMBL2558	Homo sapiens	Inhibition	%	-0.72
	8116794	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.88	CHEMBL2558	Homo sapiens	Inhibition	%	-0.88
	8116966	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.2	CHEMBL2558	Homo sapiens	Inhibition	%	3.2
	8117137	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.75	CHEMBL2558	Homo sapiens	Inhibition	%	-0.75
	8117361	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.39	CHEMBL2558	Homo sapiens	Inhibition	%	-0.39
	8117519	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-0.74	CHEMBL2558	Homo sapiens	Inhibition	%	-0.74
	8117873	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl	Outside typical range	CHEMBL529066	=	Inhibition	%	-10.66	CHEMBL2558	Homo sapiens	Inhibition	%	-10.66
	8118011	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.38	CHEMBL2558	Homo sapiens	Inhibition	%	3.38
	8118351	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.52	CHEMBL2558	Homo sapiens	Inhibition	%	1.52
	8118523	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.63	CHEMBL2558	Homo sapiens	Inhibition	%	5.63
	8118747	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-3.14	CHEMBL2558	Homo sapiens	Inhibition	%	-3.14
	8118883	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	11.06	CHEMBL2558	Homo sapiens	Inhibition	%	11.06
	8119154	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.58	CHEMBL2558	Homo sapiens	Inhibition	%	1.58
	8119313	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	4.75	CHEMBL2558	Homo sapiens	Inhibition	%	4.75
	8119537	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-5.64	CHEMBL2558	Homo sapiens	Inhibition	%	-5.64
	8119704	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	7.63	CHEMBL2558	Homo sapiens	Inhibition	%	7.63
	8120047	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	6.48	CHEMBL2558	Homo sapiens	Inhibition	%	6.48
	8120186	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.74	CHEMBL2558	Homo sapiens	Inhibition	%	2.74
	8120570	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.35	CHEMBL2558	Homo sapiens	Inhibition	%	-0.35
	8120771	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	5.68	CHEMBL2558	Homo sapiens	Inhibition	%	5.68
	8121123	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.66	CHEMBL2558	Homo sapiens	Inhibition	%	-1.66
	8121295	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.84	CHEMBL2558	Homo sapiens	Inhibition	%	4.84
	8121686	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-1.65	CHEMBL2558	Homo sapiens	Inhibition	%	-1.65
	8121849	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	12.35	CHEMBL2558	Homo sapiens	Inhibition	%	12.35
	8122194	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.64	CHEMBL2558	Homo sapiens	Inhibition	%	0.64
	8122332	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.08	CHEMBL2558	Homo sapiens	Inhibition	%	2.08
	8122556	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	5.66	CHEMBL2558	Homo sapiens	Inhibition	%	5.66
	8122676	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.56	CHEMBL2558	Homo sapiens	Inhibition	%	0.56
	8123067	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-5.12	CHEMBL2558	Homo sapiens	Inhibition	%	-5.12
	8123209	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	4.32	CHEMBL2558	Homo sapiens	Inhibition	%	4.32
	8123487	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	34.99	CHEMBL2558	Homo sapiens	Inhibition	%	34.99
	8123861	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-5.67	CHEMBL2558	Homo sapiens	Inhibition	%	-5.67
	8124028	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.67	CHEMBL2558	Homo sapiens	Inhibition	%	-0.67
	8124371	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-0.58	CHEMBL2558	Homo sapiens	Inhibition	%	-0.58
	8124510	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.35	CHEMBL2558	Homo sapiens	Inhibition	%	1.35
	8124734	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.31	CHEMBL2558	Homo sapiens	Inhibition	%	3.31
	8124899	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.55	CHEMBL2558	Homo sapiens	Inhibition	%	-1.55
	8125100	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.58	CHEMBL2558	Homo sapiens	Inhibition	%	4.58
	8125324	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.64	CHEMBL2558	Homo sapiens	Inhibition	%	4.64
	8125454	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.32	CHEMBL2558	Homo sapiens	Inhibition	%	-1.32
	8125622	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.13	CHEMBL2558	Homo sapiens	Inhibition	%	2.13
	8125846	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.66	CHEMBL2558	Homo sapiens	Inhibition	%	3.66
	8126010	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.72	CHEMBL2558	Homo sapiens	Inhibition	%	-0.72
	8126174	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	10.57	CHEMBL2558	Homo sapiens	Inhibition	%	10.57
	8126398	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.68	CHEMBL2558	Homo sapiens	Inhibition	%	2.68
	8126513	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.06	CHEMBL2558	Homo sapiens	Inhibition	%	1.06
	8126873	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	9.33	CHEMBL2558	Homo sapiens	Inhibition	%	9.33
	8126995	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	12.39	CHEMBL2558	Homo sapiens	Inhibition	%	12.39
	8127219	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	13.22	CHEMBL2558	Homo sapiens	Inhibition	%	13.22
	8127386	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.21	CHEMBL2558	Homo sapiens	Inhibition	%	7.21
	8127528	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-4.22	CHEMBL2558	Homo sapiens	Inhibition	%	-4.22
	8127752	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	8.33	CHEMBL2558	Homo sapiens	Inhibition	%	8.33
	8127816	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	8.86	CHEMBL2558	Homo sapiens	Inhibition	%	8.86
	8128040	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	11.89	CHEMBL2558	Homo sapiens	Inhibition	%	11.89
	8128192	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.93	CHEMBL2558	Homo sapiens	Inhibition	%	3.93
	8128359	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.81	CHEMBL2558	Homo sapiens	Inhibition	%	-2.81
	8128583	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.15	CHEMBL2558	Homo sapiens	Inhibition	%	2.15
	8128702	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.16	CHEMBL2558	Homo sapiens	Inhibition	%	0.16
	8129063	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.81	CHEMBL2558	Homo sapiens	Inhibition	%	1.81
	8129234	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.01	CHEMBL2558	Homo sapiens	Inhibition	%	-1.01
	8129647	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.86	CHEMBL2558	Homo sapiens	Inhibition	%	2.86
	8129786	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-2.01	CHEMBL2558	Homo sapiens	Inhibition	%	-2.01
	8130171	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.17	CHEMBL2558	Homo sapiens	Inhibition	%	2.17
	8130343	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.64	CHEMBL2558	Homo sapiens	Inhibition	%	-1.64
	8130727	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.28	CHEMBL2558	Homo sapiens	Inhibition	%	1.28
	8130843	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.95	CHEMBL2558	Homo sapiens	Inhibition	%	1.95
	8131206	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-3.82	CHEMBL2558	Homo sapiens	Inhibition	%	-3.82
	8131550	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.32	CHEMBL2558	Homo sapiens	Inhibition	%	3.32
	8131717	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.0	CHEMBL2558	Homo sapiens	Inhibition	%	7.0
	8132082	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.16	CHEMBL2558	Homo sapiens	Inhibition	%	4.16
	8132368	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.19	CHEMBL2558	Homo sapiens	Inhibition	%	0.19
	8132515	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	5.28	CHEMBL2558	Homo sapiens	Inhibition	%	5.28
	8132907	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.77	CHEMBL2558	Homo sapiens	Inhibition	%	1.77
	8133028	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	9.28	CHEMBL2558	Homo sapiens	Inhibition	%	9.28
	8133252	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	11.78	CHEMBL2558	Homo sapiens	Inhibition	%	11.78
	8133390	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.62	CHEMBL2558	Homo sapiens	Inhibition	%	3.62
	8133562	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.18	CHEMBL2558	Homo sapiens	Inhibition	%	-1.18
	8133786	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.42	CHEMBL2558	Homo sapiens	Inhibition	%	-1.42
	8133966	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.64	CHEMBL2558	Homo sapiens	Inhibition	%	2.64
	8134114	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.84	CHEMBL2558	Homo sapiens	Inhibition	%	-1.84
	8134338	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-3.05	CHEMBL2558	Homo sapiens	Inhibition	%	-3.05
	8134498	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.89	CHEMBL2558	Homo sapiens	Inhibition	%	3.89
	8134682	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.81	CHEMBL2558	Homo sapiens	Inhibition	%	-1.81
	8135066	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	6.16	CHEMBL2558	Homo sapiens	Inhibition	%	6.16
	8135181	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.74	CHEMBL2558	Homo sapiens	Inhibition	%	-0.74
	8135405	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	12.83	CHEMBL2558	Homo sapiens	Inhibition	%	12.83
	8135546	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-5.02	CHEMBL2558	Homo sapiens	Inhibition	%	-5.02
	8135891	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.27	CHEMBL2558	Homo sapiens	Inhibition	%	3.27
	8136059	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-0.06	CHEMBL2558	Homo sapiens	Inhibition	%	-0.06
	8136283	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-2.35	CHEMBL2558	Homo sapiens	Inhibition	%	-2.35
	8136427	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-1.22	CHEMBL2558	Homo sapiens	Inhibition	%	-1.22
	8136717	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.79	CHEMBL2558	Homo sapiens	Inhibition	%	1.79
	8136852	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-2.03	CHEMBL2558	Homo sapiens	Inhibition	%	-2.03
	8137076	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-1.58	CHEMBL2558	Homo sapiens	Inhibition	%	-1.58
	8137239	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-6.43	CHEMBL2558	Homo sapiens	Inhibition	%	-6.43
	8137583	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.17	CHEMBL2558	Homo sapiens	Inhibition	%	0.17
	8137731	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.28	CHEMBL2558	Homo sapiens	Inhibition	%	3.28
	8138121	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.35	CHEMBL2558	Homo sapiens	Inhibition	%	-2.35
	8138300	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.32	CHEMBL2558	Homo sapiens	Inhibition	%	3.32
	8138672	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.08	CHEMBL2558	Homo sapiens	Inhibition	%	-2.08
	8138830	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.7	CHEMBL2558	Homo sapiens	Inhibition	%	4.7
	8139015	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.55	CHEMBL2558	Homo sapiens	Inhibition	%	-2.55
	8139239	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.46	CHEMBL2558	Homo sapiens	Inhibition	%	1.46
	8139398	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.15	CHEMBL2558	Homo sapiens	Inhibition	%	4.15
	8139736	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	10.93	CHEMBL2558	Homo sapiens	Inhibition	%	10.93
	8139877	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.57	CHEMBL2558	Homo sapiens	Inhibition	%	6.57
	8140101	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.25	CHEMBL2558	Homo sapiens	Inhibition	%	6.25
	8140224	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	7.6	CHEMBL2558	Homo sapiens	Inhibition	%	7.6
	8140607	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	10.61	CHEMBL2558	Homo sapiens	Inhibition	%	10.61
	8140750	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-4.62	CHEMBL2558	Homo sapiens	Inhibition	%	-4.62
	8141052	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.95	CHEMBL2558	Homo sapiens	Inhibition	%	2.95
	8141406	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	7.38	CHEMBL2558	Homo sapiens	Inhibition	%	7.38
	8141566	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-8.41	CHEMBL2558	Homo sapiens	Inhibition	%	-8.41
	8141909	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.45	CHEMBL2558	Homo sapiens	Inhibition	%	0.45
	8142070	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.51	CHEMBL2558	Homo sapiens	Inhibition	%	2.51
	8142294	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.06	CHEMBL2558	Homo sapiens	Inhibition	%	2.06
	8142462	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.34	CHEMBL2558	Homo sapiens	Inhibition	%	-1.34
	8142638	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.59	CHEMBL2558	Homo sapiens	Inhibition	%	2.59
	8143011	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.3	CHEMBL2558	Homo sapiens	Inhibition	%	-2.3
	8143166	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.63	CHEMBL2558	Homo sapiens	Inhibition	%	4.63
	8143390	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.54	CHEMBL2558	Homo sapiens	Inhibition	%	1.54
	8143577	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-4.68	CHEMBL2558	Homo sapiens	Inhibition	%	-4.68
	8143736	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-4.51	CHEMBL2558	Homo sapiens	Inhibition	%	-4.51
	8144074	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.45	CHEMBL2558	Homo sapiens	Inhibition	%	3.45
	8144437	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-0.19	CHEMBL2558	Homo sapiens	Inhibition	%	-0.19
	8144567	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	7.15	CHEMBL2558	Homo sapiens	Inhibition	%	7.15
	8144944	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	9.63	CHEMBL2558	Homo sapiens	Inhibition	%	9.63
	8145081	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	8.91	CHEMBL2558	Homo sapiens	Inhibition	%	8.91
	8145305	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.96	CHEMBL2558	Homo sapiens	Inhibition	%	6.96
	8145394	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	5.32	CHEMBL2558	Homo sapiens	Inhibition	%	5.32
	8145742	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	8.47	CHEMBL2558	Homo sapiens	Inhibition	%	8.47
	8145903	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.55	CHEMBL2558	Homo sapiens	Inhibition	%	4.55
	8146127	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.43	CHEMBL2558	Homo sapiens	Inhibition	%	4.43
	8146247	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	3.64	CHEMBL2558	Homo sapiens	Inhibition	%	3.64
	8146631	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.17	CHEMBL2558	Homo sapiens	Inhibition	%	2.17
	8146798	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	3.7	CHEMBL2558	Homo sapiens	Inhibition	%	3.7
	8146967	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.49	CHEMBL2558	Homo sapiens	Inhibition	%	2.49
	8147191	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.28	CHEMBL2558	Homo sapiens	Inhibition	%	1.28
	8147333	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.36	CHEMBL2558	Homo sapiens	Inhibition	%	3.36
	8147710	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.24	CHEMBL2558	Homo sapiens	Inhibition	%	4.24
	8147897	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	9.92	CHEMBL2558	Homo sapiens	Inhibition	%	9.92
	8148055	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-5.56	CHEMBL2558	Homo sapiens	Inhibition	%	-5.56
	8148279	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.27	CHEMBL2558	Homo sapiens	Inhibition	%	6.27
	8148393	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.27	CHEMBL2558	Homo sapiens	Inhibition	%	2.27
	8148756	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-2.5	CHEMBL2558	Homo sapiens	Inhibition	%	-2.5
	8148894	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-2.59	CHEMBL2558	Homo sapiens	Inhibition	%	-2.59
	8149118	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-3.98	CHEMBL2558	Homo sapiens	Inhibition	%	-3.98
	8149277	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.47	CHEMBL2558	Homo sapiens	Inhibition	%	-0.47
	8149635	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.2	CHEMBL2558	Homo sapiens	Inhibition	%	3.2
	8149733	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-4.67	CHEMBL2558	Homo sapiens	Inhibition	%	-4.67
	8149957	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-3.09	CHEMBL2558	Homo sapiens	Inhibition	%	-3.09
	8150082	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-1.4	CHEMBL2558	Homo sapiens	Inhibition	%	-1.4
	8150466	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.4	CHEMBL2558	Homo sapiens	Inhibition	%	-1.4
	8150586	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	4.23	CHEMBL2558	Homo sapiens	Inhibition	%	4.23
	8150975	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	4.14	CHEMBL2558	Homo sapiens	Inhibition	%	4.14
	8151138	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.57	CHEMBL2558	Homo sapiens	Inhibition	%	-2.57
	8151539	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.5	CHEMBL2558	Homo sapiens	Inhibition	%	3.5
	8151677	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.95	CHEMBL2558	Homo sapiens	Inhibition	%	1.95
	8152055	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.26	CHEMBL2558	Homo sapiens	Inhibition	%	2.26
	8152243	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-8.17	CHEMBL2558	Homo sapiens	Inhibition	%	-8.17
	8152625	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.31	CHEMBL2558	Homo sapiens	Inhibition	%	5.31
	8152739	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	7.35	CHEMBL2558	Homo sapiens	Inhibition	%	7.35
	8152963	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.98	CHEMBL2558	Homo sapiens	Inhibition	%	4.98
	8153102	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	9.3	CHEMBL2558	Homo sapiens	Inhibition	%	9.3
	8153463	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	8.7	CHEMBL2558	Homo sapiens	Inhibition	%	8.7
	8153620	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.52	CHEMBL2558	Homo sapiens	Inhibition	%	-1.52
	8153977	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	0.19	CHEMBL2558	Homo sapiens	Inhibition	%	0.19
	8154298	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.46	CHEMBL2558	Homo sapiens	Inhibition	%	4.46
	8154424	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-1.29	CHEMBL2558	Homo sapiens	Inhibition	%	-1.29
	8154648	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.88	CHEMBL2558	Homo sapiens	Inhibition	%	0.88
	8154807	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.89	CHEMBL2558	Homo sapiens	Inhibition	%	-1.89
	8154927	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-5.36	CHEMBL2558	Homo sapiens	Inhibition	%	-5.36
	8155151	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-5.36	CHEMBL2558	Homo sapiens	Inhibition	%	-5.36
	8155327	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.24	CHEMBL2558	Homo sapiens	Inhibition	%	2.24
	8155488	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.38	CHEMBL2558	Homo sapiens	Inhibition	%	-2.38
	8155712	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.3	CHEMBL2558	Homo sapiens	Inhibition	%	2.3
	8155890	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.38	CHEMBL2558	Homo sapiens	Inhibition	%	1.38
	8156028	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.1	CHEMBL2558	Homo sapiens	Inhibition	%	3.1
	8156252	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.54	CHEMBL2558	Homo sapiens	Inhibition	%	1.54
	8156464	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.63	CHEMBL2558	Homo sapiens	Inhibition	%	3.63
	8156614	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.26	CHEMBL2558	Homo sapiens	Inhibition	%	3.26
	8156838	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.05	CHEMBL2558	Homo sapiens	Inhibition	%	4.05
	8156981	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.56	CHEMBL2558	Homo sapiens	Inhibition	%	4.56
	8157325	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.3	CHEMBL2558	Homo sapiens	Inhibition	%	4.3
	8157466	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-0.52	CHEMBL2558	Homo sapiens	Inhibition	%	-0.52
	8157820	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-4.35	CHEMBL2558	Homo sapiens	Inhibition	%	-4.35
	8157981	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	9.42	CHEMBL2558	Homo sapiens	Inhibition	%	9.42
	8158205	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.32	CHEMBL2558	Homo sapiens	Inhibition	%	-0.32
	8158231	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-3.68	CHEMBL2558	Homo sapiens	Inhibition	%	-3.68
	8158455	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.74	CHEMBL2558	Homo sapiens	Inhibition	%	5.74
	8158613	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.74	CHEMBL2558	Homo sapiens	Inhibition	%	5.74
	8158782	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.82	CHEMBL2558	Homo sapiens	Inhibition	%	-0.82
	8159006	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.43	CHEMBL2558	Homo sapiens	Inhibition	%	-0.43
	8159141	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-1.79	CHEMBL2558	Homo sapiens	Inhibition	%	-1.79
	8159485	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.64	CHEMBL2558	Homo sapiens	Inhibition	%	-0.64
	8159616	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	8.63	CHEMBL2558	Homo sapiens	Inhibition	%	8.63
	8159840	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.54	CHEMBL2558	Homo sapiens	Inhibition	%	3.54
	8159981	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.91	CHEMBL2558	Homo sapiens	Inhibition	%	1.91
	8160342	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.97	CHEMBL2558	Homo sapiens	Inhibition	%	5.97
	8160492	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.1	CHEMBL2558	Homo sapiens	Inhibition	%	-1.1
	8160786	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.66	CHEMBL2558	Homo sapiens	Inhibition	%	4.66
	8161160	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.97	CHEMBL2558	Homo sapiens	Inhibition	%	4.97
	8161303	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.38	CHEMBL2558	Homo sapiens	Inhibition	%	3.38
	8161652	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.2	CHEMBL2558	Homo sapiens	Inhibition	%	3.2
	8161790	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.2	CHEMBL2558	Homo sapiens	Inhibition	%	1.2
	8162014	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	10.42	CHEMBL2558	Homo sapiens	Inhibition	%	10.42
	8162144	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-4.37	CHEMBL2558	Homo sapiens	Inhibition	%	-4.37
	8162528	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.71	CHEMBL2558	Homo sapiens	Inhibition	%	-0.71
	8162781	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	8.64	CHEMBL2558	Homo sapiens	Inhibition	%	8.64
	8162929	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	4.96	CHEMBL2558	Homo sapiens	Inhibition	%	4.96
	8163322	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	8.89	CHEMBL2558	Homo sapiens	Inhibition	%	8.89
	8163456	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.32	CHEMBL2558	Homo sapiens	Inhibition	%	-0.32
	8163680	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	8.42	CHEMBL2558	Homo sapiens	Inhibition	%	8.42
	8163803	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.77	CHEMBL2558	Homo sapiens	Inhibition	%	-1.77
	8164161	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	47.15	CHEMBL2558	Homo sapiens	Inhibition	%	47.15
	8164301	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-7.58	CHEMBL2558	Homo sapiens	Inhibition	%	-7.58
	8164680	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.73	CHEMBL2558	Homo sapiens	Inhibition	%	3.73
	8164824	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.38	CHEMBL2558	Homo sapiens	Inhibition	%	-0.38
	8165048	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.51	CHEMBL2558	Homo sapiens	Inhibition	%	2.51
	8165118	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.3	CHEMBL2558	Homo sapiens	Inhibition	%	4.3
	8165483	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.92	CHEMBL2558	Homo sapiens	Inhibition	%	3.92
	8165626	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.76	CHEMBL2558	Homo sapiens	Inhibition	%	3.76
	8165850	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.57	CHEMBL2558	Homo sapiens	Inhibition	%	1.57
	8165976	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.55	CHEMBL2558	Homo sapiens	Inhibition	%	3.55
	8166338	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	11.95	CHEMBL2558	Homo sapiens	Inhibition	%	11.95
	8166468	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.76	CHEMBL2558	Homo sapiens	Inhibition	%	5.76
	8166692	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.12	CHEMBL2558	Homo sapiens	Inhibition	%	6.12
	8166793	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.65	CHEMBL2558	Homo sapiens	Inhibition	%	2.65
	8167105	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-1.49	CHEMBL2558	Homo sapiens	Inhibition	%	-1.49
	8167246	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	24.93	CHEMBL2558	Homo sapiens	Inhibition	%	24.93
	8167470	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	-1.5	CHEMBL2558	Homo sapiens	Inhibition	%	-1.5
	8167634	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	9.29	CHEMBL2558	Homo sapiens	Inhibition	%	9.29
	8167991	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	10.74	CHEMBL2558	Homo sapiens	Inhibition	%	10.74
	8168115	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.6	CHEMBL2558	Homo sapiens	Inhibition	%	1.6
	8168480	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	11.65	CHEMBL2558	Homo sapiens	Inhibition	%	11.65
	8168616	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-7.03	CHEMBL2558	Homo sapiens	Inhibition	%	-7.03
	8168840	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.4	CHEMBL2558	Homo sapiens	Inhibition	%	1.4
	8169004	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.93	CHEMBL2558	Homo sapiens	Inhibition	%	3.93
	8169370	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.64	CHEMBL2558	Homo sapiens	Inhibition	%	4.64
	8169450	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.57	CHEMBL2558	Homo sapiens	Inhibition	%	7.57
	8169674	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.26	CHEMBL2558	Homo sapiens	Inhibition	%	4.26
	8169808	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.61	CHEMBL2558	Homo sapiens	Inhibition	%	4.61
	8170177	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.18	CHEMBL2558	Homo sapiens	Inhibition	%	3.18
	8170302	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.69	CHEMBL2558	Homo sapiens	Inhibition	%	3.69
	8170526	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.75	CHEMBL2558	Homo sapiens	Inhibition	%	4.75
	8170666	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.8	CHEMBL2558	Homo sapiens	Inhibition	%	1.8
	8171025	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-1.79	CHEMBL2558	Homo sapiens	Inhibition	%	-1.79
	8171222	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.68	CHEMBL2558	Homo sapiens	Inhibition	%	1.68
	8171439	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-1.31	CHEMBL2558	Homo sapiens	Inhibition	%	-1.31
	8171804	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.25	CHEMBL2558	Homo sapiens	Inhibition	%	5.25
	8171957	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.52	CHEMBL2558	Homo sapiens	Inhibition	%	-0.52
	8172313	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	1.92	CHEMBL2558	Homo sapiens	Inhibition	%	1.92
	8172441	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.59	CHEMBL2558	Homo sapiens	Inhibition	%	1.59
	8172665	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-7.91	CHEMBL2558	Homo sapiens	Inhibition	%	-7.91
	8172807	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	15.06	CHEMBL2558	Homo sapiens	Inhibition	%	15.06
	8173167	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	3.03	CHEMBL2558	Homo sapiens	Inhibition	%	3.03
	8173332	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.45	CHEMBL2558	Homo sapiens	Inhibition	%	4.45
	8173697	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.41	CHEMBL2558	Homo sapiens	Inhibition	%	1.41
	8174008	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	12.4	CHEMBL2558	Homo sapiens	Inhibition	%	12.4
	8174140	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.88	CHEMBL2558	Homo sapiens	Inhibition	%	4.88
	8174512	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.26	CHEMBL2558	Homo sapiens	Inhibition	%	2.26
	8174858	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.17	CHEMBL2558	Homo sapiens	Inhibition	%	3.17
	8175001	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.75	CHEMBL2558	Homo sapiens	Inhibition	%	1.75
	8175361	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-2.33	CHEMBL2558	Homo sapiens	Inhibition	%	-2.33
	8175617	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	7.29	CHEMBL2558	Homo sapiens	Inhibition	%	7.29
	8175780	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	8.62	CHEMBL2558	Homo sapiens	Inhibition	%	8.62
	8176004	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	8.09	CHEMBL2558	Homo sapiens	Inhibition	%	8.09
	8176157	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.02	CHEMBL2558	Homo sapiens	Inhibition	%	7.02
	8176306	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.39	CHEMBL2558	Homo sapiens	Inhibition	%	-1.39
	8176530	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.57	CHEMBL2558	Homo sapiens	Inhibition	%	1.57
	8176662	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.63	CHEMBL2558	Homo sapiens	Inhibition	%	2.63
	8177016	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-8.69	CHEMBL2558	Homo sapiens	Inhibition	%	-8.69
	8177158	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.16	CHEMBL2558	Homo sapiens	Inhibition	%	3.16
	8177382	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.95	CHEMBL2558	Homo sapiens	Inhibition	%	3.95
	8177520	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.0	CHEMBL2558	Homo sapiens	Inhibition	%	2.0
	8177684	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.53	CHEMBL2558	Homo sapiens	Inhibition	%	4.53
	8177908	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.26	CHEMBL2558	Homo sapiens	Inhibition	%	4.26
	8178048	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-6.21	CHEMBL2558	Homo sapiens	Inhibition	%	-6.21
	8178360	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.79	CHEMBL2558	Homo sapiens	Inhibition	%	1.79
	8178487	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.55	CHEMBL2558	Homo sapiens	Inhibition	%	5.55
	8178711	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.6	CHEMBL2558	Homo sapiens	Inhibition	%	4.6
	8178860	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.86	CHEMBL2558	Homo sapiens	Inhibition	%	3.86
	8179207	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.45	CHEMBL2558	Homo sapiens	Inhibition	%	3.45
	8179351	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.72	CHEMBL2558	Homo sapiens	Inhibition	%	4.72
	8179575	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.92	CHEMBL2558	Homo sapiens	Inhibition	%	4.92
	8179712	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	8.24	CHEMBL2558	Homo sapiens	Inhibition	%	8.24
	8179969	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-2.19	CHEMBL2558	Homo sapiens	Inhibition	%	-2.19
	8180347	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.32	CHEMBL2558	Homo sapiens	Inhibition	%	-1.32
	8180503	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	9.98	CHEMBL2558	Homo sapiens	Inhibition	%	9.98
	8180875	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.27	CHEMBL2558	Homo sapiens	Inhibition	%	1.27
	8181008	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	12.19	CHEMBL2558	Homo sapiens	Inhibition	%	12.19
	8181232	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	13.25	CHEMBL2558	Homo sapiens	Inhibition	%	13.25
	8181363	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.47	CHEMBL2558	Homo sapiens	Inhibition	%	1.47
	8181727	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.91	CHEMBL2558	Homo sapiens	Inhibition	%	5.91
	8181866	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	24.81	CHEMBL2558	Homo sapiens	Inhibition	%	24.81
	8182253	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.25	CHEMBL2558	Homo sapiens	Inhibition	%	4.25
	8182393	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.45	CHEMBL2558	Homo sapiens	Inhibition	%	3.45
	8182709	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.24	CHEMBL2558	Homo sapiens	Inhibition	%	2.24
	8183055	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.45	CHEMBL2558	Homo sapiens	Inhibition	%	5.45
	8183204	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.65	CHEMBL2558	Homo sapiens	Inhibition	%	2.65
	8183428	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.19	CHEMBL2558	Homo sapiens	Inhibition	%	4.19
	8183557	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.54	CHEMBL2558	Homo sapiens	Inhibition	%	1.54
	8183923	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-4.0	CHEMBL2558	Homo sapiens	Inhibition	%	-4.0
	8184059	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	8.65	CHEMBL2558	Homo sapiens	Inhibition	%	8.65
	8184325	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-2.32	CHEMBL2558	Homo sapiens	Inhibition	%	-2.32
	8184696	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.65	CHEMBL2558	Homo sapiens	Inhibition	%	-2.65
	8184853	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.23	CHEMBL2558	Homo sapiens	Inhibition	%	0.23
	8185077	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.12	CHEMBL2558	Homo sapiens	Inhibition	%	2.12
	8185226	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-6.93	CHEMBL2558	Homo sapiens	Inhibition	%	-6.93
	8185581	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.32	CHEMBL2558	Homo sapiens	Inhibition	%	3.32
	8185712	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.66	CHEMBL2558	Homo sapiens	Inhibition	%	1.66
	8186075	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	7.04	CHEMBL2558	Homo sapiens	Inhibition	%	7.04
	8186216	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.63	CHEMBL2558	Homo sapiens	Inhibition	%	4.63
	8186440	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	6.8	CHEMBL2558	Homo sapiens	Inhibition	%	6.8
	8186604	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.58	CHEMBL2558	Homo sapiens	Inhibition	%	3.58
	8186743	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.85	CHEMBL2558	Homo sapiens	Inhibition	%	4.85
	8186967	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.93	CHEMBL2558	Homo sapiens	Inhibition	%	3.93
	8187065	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.68	CHEMBL2558	Homo sapiens	Inhibition	%	1.68
	8187289	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.91	CHEMBL2558	Homo sapiens	Inhibition	%	1.91
	8187413	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.2	CHEMBL2558	Homo sapiens	Inhibition	%	5.2
	8187785	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.61	CHEMBL2558	Homo sapiens	Inhibition	%	2.61
	8187914	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.79	CHEMBL2558	Homo sapiens	Inhibition	%	1.79
	8188281	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-3.71	CHEMBL2558	Homo sapiens	Inhibition	%	-3.71
	8188416	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-1.65	CHEMBL2558	Homo sapiens	Inhibition	%	-1.65
	8188640	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.35	CHEMBL2558	Homo sapiens	Inhibition	%	-2.35
	8188690	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.62	CHEMBL2558	Homo sapiens	Inhibition	%	6.62
	8188914	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	8.39	CHEMBL2558	Homo sapiens	Inhibition	%	8.39
	8189062	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.63	CHEMBL2558	Homo sapiens	Inhibition	%	1.63
	8189442	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	10.59	CHEMBL2558	Homo sapiens	Inhibition	%	10.59
	8189591	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-8.59	CHEMBL2558	Homo sapiens	Inhibition	%	-8.59
	8189947	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.74	CHEMBL2558	Homo sapiens	Inhibition	%	2.74
	8190079	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.98	CHEMBL2558	Homo sapiens	Inhibition	%	0.98
	8190303	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.6	CHEMBL2558	Homo sapiens	Inhibition	%	4.6
	8190443	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-2.69	CHEMBL2558	Homo sapiens	Inhibition	%	-2.69
	8190804	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.37	CHEMBL2558	Homo sapiens	Inhibition	%	4.37
	8190968	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.07	CHEMBL2558	Homo sapiens	Inhibition	%	4.07
	8191330	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.89	CHEMBL2558	Homo sapiens	Inhibition	%	4.89
	8191650	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.86	CHEMBL2558	Homo sapiens	Inhibition	%	0.86
	8191772	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.37	CHEMBL2558	Homo sapiens	Inhibition	%	5.37
	8192145	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.2	CHEMBL2558	Homo sapiens	Inhibition	%	4.2
	8192274	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	9.67	CHEMBL2558	Homo sapiens	Inhibition	%	9.67
	8192498	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	10.17	CHEMBL2558	Homo sapiens	Inhibition	%	10.17
	8192642	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.54	CHEMBL2558	Homo sapiens	Inhibition	%	6.54
	8193002	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.8	CHEMBL2558	Homo sapiens	Inhibition	%	0.8
	8193274	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.26	CHEMBL2558	Homo sapiens	Inhibition	%	1.26
	8193419	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.9	CHEMBL2558	Homo sapiens	Inhibition	%	0.9
	8193800	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	12.49	CHEMBL2558	Homo sapiens	Inhibition	%	12.49
	8193949	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.86	CHEMBL2558	Homo sapiens	Inhibition	%	0.86
	8194173	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.8	CHEMBL2558	Homo sapiens	Inhibition	%	0.8
	8194304	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.4	CHEMBL2558	Homo sapiens	Inhibition	%	6.4
	8194659	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	11.14	CHEMBL2558	Homo sapiens	Inhibition	%	11.14
	8194802	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-2.35	CHEMBL2558	Homo sapiens	Inhibition	%	-2.35
	8195159	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.18	CHEMBL2558	Homo sapiens	Inhibition	%	5.18
	8195323	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	-0.53	CHEMBL2558	Homo sapiens	Inhibition	%	-0.53
	8195547	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1	Outside typical range	CHEMBL1789963	=	Inhibition	%	-13.7	CHEMBL2558	Homo sapiens	Inhibition	%	-13.7
	8195686	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.31	CHEMBL2558	Homo sapiens	Inhibition	%	4.31
	8196008	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.67	CHEMBL2558	Homo sapiens	Inhibition	%	0.67
	8196125	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.43	CHEMBL2558	Homo sapiens	Inhibition	%	3.43
	8196349	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.17	CHEMBL2558	Homo sapiens	Inhibition	%	5.17
	8196499	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.42	CHEMBL2558	Homo sapiens	Inhibition	%	3.42
	8196851	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.06	CHEMBL2558	Homo sapiens	Inhibition	%	0.06
	8196992	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	7.67	CHEMBL2558	Homo sapiens	Inhibition	%	7.67
	8197353	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.23	CHEMBL2558	Homo sapiens	Inhibition	%	1.23
	8197628	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.25	CHEMBL2558	Homo sapiens	Inhibition	%	1.25
	8197768	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-8.75	CHEMBL2558	Homo sapiens	Inhibition	%	-8.75
	8197992	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC	Outside typical range	CHEMBL514162	=	Inhibition	%	-14.96	CHEMBL2558	Homo sapiens	Inhibition	%	-14.96
	8198149	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.36	CHEMBL2558	Homo sapiens	Inhibition	%	2.36
	8198511	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.73	CHEMBL2558	Homo sapiens	Inhibition	%	0.73
	8198641	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.25	CHEMBL2558	Homo sapiens	Inhibition	%	6.25
	8198996	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	13.8	CHEMBL2558	Homo sapiens	Inhibition	%	13.8
	8199144	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.94	CHEMBL2558	Homo sapiens	Inhibition	%	5.94
	8199368	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.51	CHEMBL2558	Homo sapiens	Inhibition	%	7.51
	8199502	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.08	CHEMBL2558	Homo sapiens	Inhibition	%	5.08
	8199889	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.5	CHEMBL2558	Homo sapiens	Inhibition	%	1.5
	8200027	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.09	CHEMBL2558	Homo sapiens	Inhibition	%	6.09
	8200355	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.42	CHEMBL2558	Homo sapiens	Inhibition	%	0.42
	8200694	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.22	CHEMBL2558	Homo sapiens	Inhibition	%	4.22
	8200844	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	5.85	CHEMBL2558	Homo sapiens	Inhibition	%	5.85
	8201198	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-2.56	CHEMBL2558	Homo sapiens	Inhibition	%	-2.56
	8201333	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.1	CHEMBL2558	Homo sapiens	Inhibition	%	1.1
	8201557	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.02	CHEMBL2558	Homo sapiens	Inhibition	%	1.02
	8201690	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-9.46	CHEMBL2558	Homo sapiens	Inhibition	%	-9.46
	8201969	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	11.72	CHEMBL2558	Homo sapiens	Inhibition	%	11.72
	8202333	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.32	CHEMBL2558	Homo sapiens	Inhibition	%	0.32
	8202500	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.21	CHEMBL2558	Homo sapiens	Inhibition	%	2.21
	8202849	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.05	CHEMBL2558	Homo sapiens	Inhibition	%	3.05
	8202979	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-2.51	CHEMBL2558	Homo sapiens	Inhibition	%	-2.51
	8203203	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-2.71	CHEMBL2558	Homo sapiens	Inhibition	%	-2.71
	8203334	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.95	CHEMBL2558	Homo sapiens	Inhibition	%	2.95
	8203704	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-0.4	CHEMBL2558	Homo sapiens	Inhibition	%	-0.4
	8203838	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.6	CHEMBL2558	Homo sapiens	Inhibition	%	5.6
	8204062	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.21	CHEMBL2558	Homo sapiens	Inhibition	%	5.21
	8204228	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.3	CHEMBL2558	Homo sapiens	Inhibition	%	1.3
	8204365	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.99	CHEMBL2558	Homo sapiens	Inhibition	%	3.99
	8204589	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	5.29	CHEMBL2558	Homo sapiens	Inhibition	%	5.29
	8204694	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.24	CHEMBL2558	Homo sapiens	Inhibition	%	-0.24
	8205033	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.2	CHEMBL2558	Homo sapiens	Inhibition	%	4.2
	8205182	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.51	CHEMBL2558	Homo sapiens	Inhibition	%	3.51
	8205406	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.38	CHEMBL2558	Homo sapiens	Inhibition	%	3.38
	8205542	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.66	CHEMBL2558	Homo sapiens	Inhibition	%	3.66
	8205905	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	11.46	CHEMBL2558	Homo sapiens	Inhibition	%	11.46
	8206037	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-9.4	CHEMBL2558	Homo sapiens	Inhibition	%	-9.4
	8206261	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.43	CHEMBL2558	Homo sapiens	Inhibition	%	0.43
	8206313	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	12.35	CHEMBL2558	Homo sapiens	Inhibition	%	12.35
	8206537	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.85	CHEMBL2558	Homo sapiens	Inhibition	%	2.85
	8206680	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-4.53	CHEMBL2558	Homo sapiens	Inhibition	%	-4.53
	8206860	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.9	CHEMBL2558	Homo sapiens	Inhibition	%	4.9
	8207084	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	5.9	CHEMBL2558	Homo sapiens	Inhibition	%	5.9
	8207210	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	11.96	CHEMBL2558	Homo sapiens	Inhibition	%	11.96
	8207564	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.9	CHEMBL2558	Homo sapiens	Inhibition	%	5.9
	8207696	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.66	CHEMBL2558	Homo sapiens	Inhibition	%	3.66
	8207920	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	6.37	CHEMBL2558	Homo sapiens	Inhibition	%	6.37
	8208065	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-0.07	CHEMBL2558	Homo sapiens	Inhibition	%	-0.07
	8208421	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.22	CHEMBL2558	Homo sapiens	Inhibition	%	6.22
	8208587	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.55	CHEMBL2558	Homo sapiens	Inhibition	%	0.55
	8208944	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.98	CHEMBL2558	Homo sapiens	Inhibition	%	2.98
	8209049	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.16	CHEMBL2558	Homo sapiens	Inhibition	%	-0.16
	8209273	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.11	CHEMBL2558	Homo sapiens	Inhibition	%	-0.11
	8209389	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.05	CHEMBL2558	Homo sapiens	Inhibition	%	4.05
	8209763	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.27	CHEMBL2558	Homo sapiens	Inhibition	%	3.27
	8209899	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.18	CHEMBL2558	Homo sapiens	Inhibition	%	3.18
	8210123	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-5.15	CHEMBL2558	Homo sapiens	Inhibition	%	-5.15
	8210264	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	12.36	CHEMBL2558	Homo sapiens	Inhibition	%	12.36
	8210624	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.46	CHEMBL2558	Homo sapiens	Inhibition	%	1.46
	8210883	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.9	CHEMBL2558	Homo sapiens	Inhibition	%	1.9
	8211027	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.08	CHEMBL2558	Homo sapiens	Inhibition	%	0.08
	8211421	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-3.56	CHEMBL2558	Homo sapiens	Inhibition	%	-3.56
	8211544	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	15.41	CHEMBL2558	Homo sapiens	Inhibition	%	15.41
	8211897	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	3.27	CHEMBL2558	Homo sapiens	Inhibition	%	3.27
	8212253	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	7.29	CHEMBL2558	Homo sapiens	Inhibition	%	7.29
	8212394	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	9.31	CHEMBL2558	Homo sapiens	Inhibition	%	9.31
	8212751	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.32	CHEMBL2558	Homo sapiens	Inhibition	%	5.32
	8212921	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.51	CHEMBL2558	Homo sapiens	Inhibition	%	0.51
	8213274	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.0	CHEMBL2558	Homo sapiens	Inhibition	%	4.0
	8213602	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.53	CHEMBL2558	Homo sapiens	Inhibition	%	-1.53
	8213715	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.99	CHEMBL2558	Homo sapiens	Inhibition	%	3.99
	8213939	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.99	CHEMBL2558	Homo sapiens	Inhibition	%	3.99
	8214086	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.32	CHEMBL2558	Homo sapiens	Inhibition	%	4.32
	8214447	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-9.77	CHEMBL2558	Homo sapiens	Inhibition	%	-9.77
	8214581	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.62	CHEMBL2558	Homo sapiens	Inhibition	%	1.62
	8214957	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	1.0	CHEMBL2558	Homo sapiens	Inhibition	%	1.0
	8215208	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.49	CHEMBL2558	Homo sapiens	Inhibition	%	5.49
	8215361	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.94	CHEMBL2558	Homo sapiens	Inhibition	%	1.94
	8215585	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	10.78	CHEMBL2558	Homo sapiens	Inhibition	%	10.78
	8215749	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-3.4	CHEMBL2558	Homo sapiens	Inhibition	%	-3.4
	8215868	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	9.94	CHEMBL2558	Homo sapiens	Inhibition	%	9.94
	8216092	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	46.83	CHEMBL2558	Homo sapiens	Inhibition	%	46.83
	8216211	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.43	CHEMBL2558	Homo sapiens	Inhibition	%	-0.43
	8216571	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-1.94	CHEMBL2558	Homo sapiens	Inhibition	%	-1.94
	8216709	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	9.97	CHEMBL2558	Homo sapiens	Inhibition	%	9.97
	8216933	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.26	CHEMBL2558	Homo sapiens	Inhibition	%	-0.26
	8217067	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.03	CHEMBL2558	Homo sapiens	Inhibition	%	6.03
	8217241	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.04	CHEMBL2558	Homo sapiens	Inhibition	%	0.04
	8217465	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.04	CHEMBL2558	Homo sapiens	Inhibition	%	0.04
	8217596	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.5	CHEMBL2558	Homo sapiens	Inhibition	%	3.5
	8217921	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.43	CHEMBL2558	Homo sapiens	Inhibition	%	-1.43
	8218260	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.09	CHEMBL2558	Homo sapiens	Inhibition	%	5.09
	8218387	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.46	CHEMBL2558	Homo sapiens	Inhibition	%	3.46
	8218754	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	5.33	CHEMBL2558	Homo sapiens	Inhibition	%	5.33
	8218885	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.43	CHEMBL2558	Homo sapiens	Inhibition	%	0.43
	8219109	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.99	CHEMBL2558	Homo sapiens	Inhibition	%	4.99
	8219269	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	1.17	CHEMBL2558	Homo sapiens	Inhibition	%	1.17
	8219519	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.9	CHEMBL2558	Homo sapiens	Inhibition	%	5.9
	8219904	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	12.91	CHEMBL2558	Homo sapiens	Inhibition	%	12.91
	8220073	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.23	CHEMBL2558	Homo sapiens	Inhibition	%	5.23
	8220426	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	7.19	CHEMBL2558	Homo sapiens	Inhibition	%	7.19
	8220540	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.59	CHEMBL2558	Homo sapiens	Inhibition	%	-0.59
	8220764	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	9.05	CHEMBL2558	Homo sapiens	Inhibition	%	9.05
	8220902	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-2.93	CHEMBL2558	Homo sapiens	Inhibition	%	-2.93
	8221262	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-1.82	CHEMBL2558	Homo sapiens	Inhibition	%	-1.82
	8221395	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.88	CHEMBL2558	Homo sapiens	Inhibition	%	3.88
	8221784	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.72	CHEMBL2558	Homo sapiens	Inhibition	%	-0.72
	8221915	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	6.48	CHEMBL2558	Homo sapiens	Inhibition	%	6.48
	8222139	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.9	CHEMBL2558	Homo sapiens	Inhibition	%	3.9
	8222237	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.47	CHEMBL2558	Homo sapiens	Inhibition	%	2.47
	8222595	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.79	CHEMBL2558	Homo sapiens	Inhibition	%	3.79
	8222713	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	4.78	CHEMBL2558	Homo sapiens	Inhibition	%	4.78
	8222937	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.37	CHEMBL2558	Homo sapiens	Inhibition	%	3.37
	8223081	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.78	CHEMBL2558	Homo sapiens	Inhibition	%	4.78
	8223434	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	5.19	CHEMBL2558	Homo sapiens	Inhibition	%	5.19
	8223595	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	8.9	CHEMBL2558	Homo sapiens	Inhibition	%	8.9
	8223845	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-2.52	CHEMBL2558	Homo sapiens	Inhibition	%	-2.52
	8224231	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.4	CHEMBL2558	Homo sapiens	Inhibition	%	2.4
	8224401	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.66	CHEMBL2558	Homo sapiens	Inhibition	%	6.66
	8224760	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	10.75	CHEMBL2558	Homo sapiens	Inhibition	%	10.75
	8225098	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	10.04	CHEMBL2558	Homo sapiens	Inhibition	%	10.04
	8225232	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.24	CHEMBL2558	Homo sapiens	Inhibition	%	7.24
	8225594	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.93	CHEMBL2558	Homo sapiens	Inhibition	%	1.93
	8225729	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.32	CHEMBL2558	Homo sapiens	Inhibition	%	2.32
	8225953	CHEMBL1961964	GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.34	CHEMBL2558	Homo sapiens	Inhibition	%	5.34
	8226111	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.77	CHEMBL2558	Homo sapiens	Inhibition	%	-0.77
	8226460	CHEMBL1961965	GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.3	CHEMBL2558	Homo sapiens	Inhibition	%	5.3
	10838689	CHEMBL2014915	Inhibition of DAPK1 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	41.0	CHEMBL2558	Homo sapiens	INH	%	41.0
	10839541	CHEMBL2015002	Inhibition of DAPK1 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	79.0	CHEMBL2558	Homo sapiens	Activity	%	79.0
	10839660	CHEMBL2015846	Inhibition of DAPK1 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	98.0	CHEMBL2558	Homo sapiens	Activity	%	98.0
	10849602	CHEMBL2019645	Inhibition of DAPK1 assessed as remaining activity at 0.1 uM by radiolabeled kinase assay relative to control	B	CCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O		CHEMBL2017007	=	Activity	%	88.52	CHEMBL2558	Homo sapiens	Activity	%	88.52
Active	12037011	CHEMBL2149974	Inhibition of DAPK1 at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ncccc13)C2=O		CHEMBL2147767		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
	12047408	CHEMBL2157244	Inhibition of DAPK1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	8.6	CHEMBL2558	Homo sapiens	INH	%	8.6
	12138201	CHEMBL2186595	Inhibition of DAPK1 at 200 nM	B	Cc1cc(NC(=O)c2cnn3ccc(N)nc23)n(-c2cccc(Cl)c2)n1		CHEMBL2178807	>	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	12170825	CHEMBL2212692	Inhibition of DAPK1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	101.0	CHEMBL2558	Homo sapiens	Activity	%	101.0
	12172126	CHEMBL2213953	Inhibition of DAPK1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	95.0	CHEMBL2558	Homo sapiens	Activity	%	95.0
	12173669	CHEMBL2209305	Inhibition of DAPK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	40.0	CHEMBL2558	Homo sapiens	Activity	%	40.0
	12189668	CHEMBL2215625	Binding affinity to T7-phage-tagged DAPK1 by PCR analysis	B	COC(=O)c1c(Cc2ccc(C(=O)NCCO)cc2)c(=O)c2ccc(Cl)cc2n1-c1ccccc1		CHEMBL2152382	>	Kd	nM	10000.0	CHEMBL2558	Homo sapiens	Kd	uM	10.0
	12208238	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	101.0	CHEMBL2558	Homo sapiens	Residual Activity	%	101.0
	12208239	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	106.0	CHEMBL2558	Homo sapiens	Residual Activity	%	106.0
	12208240	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	109.0	CHEMBL2558	Homo sapiens	Residual Activity	%	109.0
	12208241	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208242	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	97.0	CHEMBL2558	Homo sapiens	Residual Activity	%	97.0
	12208243	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12208244	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208245	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	104.0	CHEMBL2558	Homo sapiens	Residual Activity	%	104.0
	12208246	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208247	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208248	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12208249	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208250	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	80.0	CHEMBL2558	Homo sapiens	Residual Activity	%	80.0
	12208251	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12208252	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	79.0	CHEMBL2558	Homo sapiens	Residual Activity	%	79.0
	12208253	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12208254	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	79.0	CHEMBL2558	Homo sapiens	Residual Activity	%	79.0
	12208255	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208256	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12208257	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	8.0	CHEMBL2558	Homo sapiens	Residual Activity	%	8.0
	12208258	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12208259	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	87.0	CHEMBL2558	Homo sapiens	Residual Activity	%	87.0
	12208260	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208261	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12208262	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12208263	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12208264	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12208265	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12208266	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12208267	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12208268	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12208269	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	105.0	CHEMBL2558	Homo sapiens	Residual Activity	%	105.0
	12208270	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12208271	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12208272	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208273	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12208274	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12208275	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12208276	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	79.0	CHEMBL2558	Homo sapiens	Residual Activity	%	79.0
	12208277	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	98.0	CHEMBL2558	Homo sapiens	Residual Activity	%	98.0
	12208278	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	107.0	CHEMBL2558	Homo sapiens	Residual Activity	%	107.0
	12208279	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	111.0	CHEMBL2558	Homo sapiens	Residual Activity	%	111.0
	12208280	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	101.0	CHEMBL2558	Homo sapiens	Residual Activity	%	101.0
	12208281	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208282	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12208283	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208284	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	87.0	CHEMBL2558	Homo sapiens	Residual Activity	%	87.0
	12208285	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12208286	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12208287	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	99.0	CHEMBL2558	Homo sapiens	Residual Activity	%	99.0
	12208288	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12208289	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12208290	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208291	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12208292	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	97.0	CHEMBL2558	Homo sapiens	Residual Activity	%	97.0
	12208293	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	97.0	CHEMBL2558	Homo sapiens	Residual Activity	%	97.0
	12208294	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12208295	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	106.0	CHEMBL2558	Homo sapiens	Residual Activity	%	106.0
	12208296	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208297	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	82.0	CHEMBL2558	Homo sapiens	Residual Activity	%	82.0
	12208298	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	79.0	CHEMBL2558	Homo sapiens	Residual Activity	%	79.0
	12208299	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	63.0	CHEMBL2558	Homo sapiens	Residual Activity	%	63.0
	12208300	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208301	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	97.0	CHEMBL2558	Homo sapiens	Residual Activity	%	97.0
	12208302	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	104.0	CHEMBL2558	Homo sapiens	Residual Activity	%	104.0
	12208303	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	102.0	CHEMBL2558	Homo sapiens	Residual Activity	%	102.0
	12208304	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	96.0	CHEMBL2558	Homo sapiens	Residual Activity	%	96.0
	12208305	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	96.0	CHEMBL2558	Homo sapiens	Residual Activity	%	96.0
	12208306	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	87.0	CHEMBL2558	Homo sapiens	Residual Activity	%	87.0
	12208307	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	100.0	CHEMBL2558	Homo sapiens	Residual Activity	%	100.0
	12208308	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12208309	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	98.0	CHEMBL2558	Homo sapiens	Residual Activity	%	98.0
	12208310	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	106.0	CHEMBL2558	Homo sapiens	Residual Activity	%	106.0
	12208311	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208312	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208313	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	98.0	CHEMBL2558	Homo sapiens	Residual Activity	%	98.0
	12208314	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	98.0	CHEMBL2558	Homo sapiens	Residual Activity	%	98.0
	12208315	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	75.0	CHEMBL2558	Homo sapiens	Residual Activity	%	75.0
	12208316	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	87.0	CHEMBL2558	Homo sapiens	Residual Activity	%	87.0
	12208317	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	6.0	CHEMBL2558	Homo sapiens	Residual Activity	%	6.0
	12208318	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12208319	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	97.0	CHEMBL2558	Homo sapiens	Residual Activity	%	97.0
	12208320	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208321	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	102.0	CHEMBL2558	Homo sapiens	Residual Activity	%	102.0
	12208322	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12208323	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12208324	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12208325	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208326	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12208327	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12208328	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12208329	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12208330	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	59.0	CHEMBL2558	Homo sapiens	Residual Activity	%	59.0
	12208331	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12208332	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208333	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12208334	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12208335	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12208336	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	87.0	CHEMBL2558	Homo sapiens	Residual Activity	%	87.0
	12208337	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	52.0	CHEMBL2558	Homo sapiens	Residual Activity	%	52.0
	12208338	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	57.0	CHEMBL2558	Homo sapiens	Residual Activity	%	57.0
	12208339	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	48.0	CHEMBL2558	Homo sapiens	Residual Activity	%	48.0
	12208340	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12208341	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	49.0	CHEMBL2558	Homo sapiens	Residual Activity	%	49.0
	12208342	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12208343	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12208344	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12208345	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12208346	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12208347	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12208348	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	74.0	CHEMBL2558	Homo sapiens	Residual Activity	%	74.0
	12208349	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12208350	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	105.0	CHEMBL2558	Homo sapiens	Residual Activity	%	105.0
	12208351	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12208352	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12208353	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	80.0	CHEMBL2558	Homo sapiens	Residual Activity	%	80.0
	12208354	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12208355	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12208356	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12208357	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208358	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	105.0	CHEMBL2558	Homo sapiens	Residual Activity	%	105.0
	12208359	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	96.0	CHEMBL2558	Homo sapiens	Residual Activity	%	96.0
	12208360	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12208361	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12208362	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12208363	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12208364	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	87.0	CHEMBL2558	Homo sapiens	Residual Activity	%	87.0
	12208365	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12208366	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	98.0	CHEMBL2558	Homo sapiens	Residual Activity	%	98.0
	12208367	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	101.0	CHEMBL2558	Homo sapiens	Residual Activity	%	101.0
	12208368	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12208369	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12208370	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12208371	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12208372	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12208373	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12208374	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12208375	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12208376	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	80.0	CHEMBL2558	Homo sapiens	Residual Activity	%	80.0
	12208377	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12208378	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12208379	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	96.0	CHEMBL2558	Homo sapiens	Residual Activity	%	96.0
	12211215	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	79.0	CHEMBL2558	Homo sapiens	Residual Activity	%	79.0
	12211216	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	76.0	CHEMBL2558	Homo sapiens	Residual Activity	%	76.0
	12211217	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12211218	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12211219	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	98.0	CHEMBL2558	Homo sapiens	Residual Activity	%	98.0
	12211220	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12211221	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	102.0	CHEMBL2558	Homo sapiens	Residual Activity	%	102.0
	12211222	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	101.0	CHEMBL2558	Homo sapiens	Residual Activity	%	101.0
	12211223	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	100.0	CHEMBL2558	Homo sapiens	Residual Activity	%	100.0
	12211224	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12211225	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12211226	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12211227	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12211228	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12211229	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12211230	CHEMBL2219020	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	69.0	CHEMBL2558	Homo sapiens	Residual Activity	%	69.0
	12211231	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12211232	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12211233	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	100.0	CHEMBL2558	Homo sapiens	Residual Activity	%	100.0
	12211234	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	66.0	CHEMBL2558	Homo sapiens	Residual Activity	%	66.0
	12211235	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	60.0	CHEMBL2558	Homo sapiens	Residual Activity	%	60.0
	12211236	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12211237	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12211238	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	100.0	CHEMBL2558	Homo sapiens	Residual Activity	%	100.0
	12211239	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12211240	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	99.0	CHEMBL2558	Homo sapiens	Residual Activity	%	99.0
	12211241	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12211242	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	73.0	CHEMBL2558	Homo sapiens	Residual Activity	%	73.0
	12211243	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12211244	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211245	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12211246	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	99.0	CHEMBL2558	Homo sapiens	Residual Activity	%	99.0
	12211247	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	51.0	CHEMBL2558	Homo sapiens	Residual Activity	%	51.0
	12211248	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	71.0	CHEMBL2558	Homo sapiens	Residual Activity	%	71.0
	12211249	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12211250	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	3.0	CHEMBL2558	Homo sapiens	Residual Activity	%	3.0
	12211251	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	68.0	CHEMBL2558	Homo sapiens	Residual Activity	%	68.0
	12211252	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	76.0	CHEMBL2558	Homo sapiens	Residual Activity	%	76.0
	12211253	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12211254	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	98.0	CHEMBL2558	Homo sapiens	Residual Activity	%	98.0
	12211255	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12211256	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12211257	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	62.0	CHEMBL2558	Homo sapiens	Residual Activity	%	62.0
	12211258	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	76.0	CHEMBL2558	Homo sapiens	Residual Activity	%	76.0
	12211259	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	102.0	CHEMBL2558	Homo sapiens	Residual Activity	%	102.0
	12211260	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	67.0	CHEMBL2558	Homo sapiens	Residual Activity	%	67.0
	12211261	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211262	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	69.0	CHEMBL2558	Homo sapiens	Residual Activity	%	69.0
	12211263	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12211264	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12211265	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	82.0	CHEMBL2558	Homo sapiens	Residual Activity	%	82.0
	12211266	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	76.0	CHEMBL2558	Homo sapiens	Residual Activity	%	76.0
	12211267	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12211268	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	108.0	CHEMBL2558	Homo sapiens	Residual Activity	%	108.0
	12211269	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	77.0	CHEMBL2558	Homo sapiens	Residual Activity	%	77.0
	12211270	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12211271	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	99.0	CHEMBL2558	Homo sapiens	Residual Activity	%	99.0
	12211272	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12211273	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	73.0	CHEMBL2558	Homo sapiens	Residual Activity	%	73.0
	12211274	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	64.0	CHEMBL2558	Homo sapiens	Residual Activity	%	64.0
	12211275	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	76.0	CHEMBL2558	Homo sapiens	Residual Activity	%	76.0
	12211276	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12211277	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12211278	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	97.0	CHEMBL2558	Homo sapiens	Residual Activity	%	97.0
	12211279	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12211280	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	76.0	CHEMBL2558	Homo sapiens	Residual Activity	%	76.0
	12211281	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	76.0	CHEMBL2558	Homo sapiens	Residual Activity	%	76.0
	12211282	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	69.0	CHEMBL2558	Homo sapiens	Residual Activity	%	69.0
	12211283	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	63.0	CHEMBL2558	Homo sapiens	Residual Activity	%	63.0
	12211284	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12211285	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	100.0	CHEMBL2558	Homo sapiens	Residual Activity	%	100.0
	12211286	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	99.0	CHEMBL2558	Homo sapiens	Residual Activity	%	99.0
	12211287	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12211288	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	62.0	CHEMBL2558	Homo sapiens	Residual Activity	%	62.0
	12211289	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	98.0	CHEMBL2558	Homo sapiens	Residual Activity	%	98.0
	12211290	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	78.0	CHEMBL2558	Homo sapiens	Residual Activity	%	78.0
	12211291	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	46.0	CHEMBL2558	Homo sapiens	Residual Activity	%	46.0
	12211292	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	72.0	CHEMBL2558	Homo sapiens	Residual Activity	%	72.0
	12211293	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12211294	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL2558	Homo sapiens	Residual Activity	%	100.0
	12211295	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	99.0	CHEMBL2558	Homo sapiens	Residual Activity	%	99.0
	12211296	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	80.0	CHEMBL2558	Homo sapiens	Residual Activity	%	80.0
	12211297	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	78.0	CHEMBL2558	Homo sapiens	Residual Activity	%	78.0
	12211298	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	82.0	CHEMBL2558	Homo sapiens	Residual Activity	%	82.0
	12211299	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	78.0	CHEMBL2558	Homo sapiens	Residual Activity	%	78.0
	12211300	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	106.0	CHEMBL2558	Homo sapiens	Residual Activity	%	106.0
	12211301	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211302	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	60.0	CHEMBL2558	Homo sapiens	Residual Activity	%	60.0
	12211303	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	75.0	CHEMBL2558	Homo sapiens	Residual Activity	%	75.0
	12211304	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	100.0	CHEMBL2558	Homo sapiens	Residual Activity	%	100.0
	12211305	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12211306	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	114.0	CHEMBL2558	Homo sapiens	Residual Activity	%	114.0
	12211307	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12211308	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	31.0	CHEMBL2558	Homo sapiens	Residual Activity	%	31.0
	12211309	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	78.0	CHEMBL2558	Homo sapiens	Residual Activity	%	78.0
	12211310	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	2.0	CHEMBL2558	Homo sapiens	Residual Activity	%	2.0
	12211311	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211312	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	96.0	CHEMBL2558	Homo sapiens	Residual Activity	%	96.0
	12211313	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12211314	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	104.0	CHEMBL2558	Homo sapiens	Residual Activity	%	104.0
	12211315	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	99.0	CHEMBL2558	Homo sapiens	Residual Activity	%	99.0
	12211316	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL2558	Homo sapiens	Residual Activity	%	105.0
	12211317	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	96.0	CHEMBL2558	Homo sapiens	Residual Activity	%	96.0
	12211318	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12211319	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12211320	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	67.0	CHEMBL2558	Homo sapiens	Residual Activity	%	67.0
	12211321	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12211322	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211323	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	17.0	CHEMBL2558	Homo sapiens	Residual Activity	%	17.0
	12211324	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211325	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12211326	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211327	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	71.0	CHEMBL2558	Homo sapiens	Residual Activity	%	71.0
	12211328	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	87.0	CHEMBL2558	Homo sapiens	Residual Activity	%	87.0
	12211329	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12211330	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	39.0	CHEMBL2558	Homo sapiens	Residual Activity	%	39.0
	12211331	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	41.0	CHEMBL2558	Homo sapiens	Residual Activity	%	41.0
	12211332	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	10.0	CHEMBL2558	Homo sapiens	Residual Activity	%	10.0
	12211333	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12211334	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	60.0	CHEMBL2558	Homo sapiens	Residual Activity	%	60.0
	12211335	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12211336	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	82.0	CHEMBL2558	Homo sapiens	Residual Activity	%	82.0
	12211337	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	79.0	CHEMBL2558	Homo sapiens	Residual Activity	%	79.0
	12211338	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12211339	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12211340	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	87.0	CHEMBL2558	Homo sapiens	Residual Activity	%	87.0
	12211341	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	65.0	CHEMBL2558	Homo sapiens	Residual Activity	%	65.0
	12211342	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	95.0	CHEMBL2558	Homo sapiens	Residual Activity	%	95.0
	12211343	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211344	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12211345	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	98.0	CHEMBL2558	Homo sapiens	Residual Activity	%	98.0
	12211346	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	80.0	CHEMBL2558	Homo sapiens	Residual Activity	%	80.0
	12211347	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	70.0	CHEMBL2558	Homo sapiens	Residual Activity	%	70.0
	12211348	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	65.0	CHEMBL2558	Homo sapiens	Residual Activity	%	65.0
	12211349	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	92.0	CHEMBL2558	Homo sapiens	Residual Activity	%	92.0
	12211350	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	93.0	CHEMBL2558	Homo sapiens	Residual Activity	%	93.0
	12211351	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	96.0	CHEMBL2558	Homo sapiens	Residual Activity	%	96.0
	12211352	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	85.0	CHEMBL2558	Homo sapiens	Residual Activity	%	85.0
	12211353	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	94.0	CHEMBL2558	Homo sapiens	Residual Activity	%	94.0
	12211354	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	76.0	CHEMBL2558	Homo sapiens	Residual Activity	%	76.0
	12211355	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	43.0	CHEMBL2558	Homo sapiens	Residual Activity	%	43.0
	12211356	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211357	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	97.0	CHEMBL2558	Homo sapiens	Residual Activity	%	97.0
	12211358	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	107.0	CHEMBL2558	Homo sapiens	Residual Activity	%	107.0
	12211359	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12211360	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	71.0	CHEMBL2558	Homo sapiens	Residual Activity	%	71.0
	12211361	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211362	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	86.0	CHEMBL2558	Homo sapiens	Residual Activity	%	86.0
	12211363	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	68.0	CHEMBL2558	Homo sapiens	Residual Activity	%	68.0
	12211364	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	90.0	CHEMBL2558	Homo sapiens	Residual Activity	%	90.0
	12211365	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	101.0	CHEMBL2558	Homo sapiens	Residual Activity	%	101.0
	12211366	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	80.0	CHEMBL2558	Homo sapiens	Residual Activity	%	80.0
	12211367	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	96.0	CHEMBL2558	Homo sapiens	Residual Activity	%	96.0
	12211368	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	54.0	CHEMBL2558	Homo sapiens	Residual Activity	%	54.0
	12211369	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	46.0	CHEMBL2558	Homo sapiens	Residual Activity	%	46.0
	12211370	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	77.0	CHEMBL2558	Homo sapiens	Residual Activity	%	77.0
	12211371	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	78.0	CHEMBL2558	Homo sapiens	Residual Activity	%	78.0
	12211372	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12211373	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	47.0	CHEMBL2558	Homo sapiens	Residual Activity	%	47.0
	12211374	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12211375	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	78.0	CHEMBL2558	Homo sapiens	Residual Activity	%	78.0
	12211376	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	91.0	CHEMBL2558	Homo sapiens	Residual Activity	%	91.0
	12211377	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	84.0	CHEMBL2558	Homo sapiens	Residual Activity	%	84.0
	12211378	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	72.0	CHEMBL2558	Homo sapiens	Residual Activity	%	72.0
	12211379	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	88.0	CHEMBL2558	Homo sapiens	Residual Activity	%	88.0
	12211380	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	100.0	CHEMBL2558	Homo sapiens	Residual Activity	%	100.0
	12211381	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	97.0	CHEMBL2558	Homo sapiens	Residual Activity	%	97.0
	12211382	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	62.0	CHEMBL2558	Homo sapiens	Residual Activity	%	62.0
	12211383	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	89.0	CHEMBL2558	Homo sapiens	Residual Activity	%	89.0
	12211384	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	83.0	CHEMBL2558	Homo sapiens	Residual Activity	%	83.0
	12211385	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	81.0	CHEMBL2558	Homo sapiens	Residual Activity	%	81.0
	12211386	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	75.0	CHEMBL2558	Homo sapiens	Residual Activity	%	75.0
	12211387	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	76.0	CHEMBL2558	Homo sapiens	Residual Activity	%	76.0
	12211388	CHEMBL2219021	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	55.0	CHEMBL2558	Homo sapiens	Residual Activity	%	55.0
	12626685	CHEMBL2317134	Inhibition of DAPK1 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL2558	Homo sapiens	INH	%	80.0
	12673071	CHEMBL2345621	Inhibition of recombinant DAPK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	36.0	CHEMBL2558	Homo sapiens	Activity	%	36.0
	12673072	CHEMBL2345621	Inhibition of recombinant DAPK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	54.0	CHEMBL2558	Homo sapiens	Activity	%	54.0
	12728860	CHEMBL2353144	Inhibition of DAPK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	98.0	CHEMBL2558	Homo sapiens	Activity	%	98.0
	12730001	CHEMBL2353645	Inhibition of DAPK1 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	103.0	CHEMBL2558	Homo sapiens	Activity	%	103.0
	12730249	CHEMBL2353144	Inhibition of DAPK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	101.0	CHEMBL2558	Homo sapiens	Activity	%	101.0
	12730880	CHEMBL2352480	Inhibition of DAPK1 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	94.0	CHEMBL2558	Homo sapiens	Activity	%	94.0
	13375898	CHEMBL2405308	Inhibition of DAPK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	14.0	CHEMBL2558	Homo sapiens	INH	%	14.0
	13396882	CHEMBL2410934	Inhibition of Dapk-1 (unknown origin) assessed as residual activity at 0.1 uM/L relative to control	B	CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C		CHEMBL2409175	=	Activity	%	21.0	CHEMBL2558	Homo sapiens	Activity	%	21.0
	13439874	CHEMBL2428164	Competitive binding affinity to DAPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	13442430	CHEMBL2428164	Competitive binding affinity to DAPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL2558	Homo sapiens	INH	%	85.0
	13442506	CHEMBL2429323	Binding affinity to DAPK1 (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	380.0	CHEMBL2558	Homo sapiens	Kd	uM	0.38
	13448439	CHEMBL2428164	Competitive binding affinity to DAPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	13451694	CHEMBL2428164	Competitive binding affinity to DAPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	98.0	CHEMBL2558	Homo sapiens	INH	%	98.0
Not Active	13863524	CHEMBL3101995	Inhibition of DAPK1 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Not Active	13863525	CHEMBL3101995	Inhibition of DAPK1 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
	13872171	CHEMBL3101923	Inhibition of human DAPK1 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	94.0	CHEMBL2558	Homo sapiens	Activity	%	94.0
	14582472	CHEMBL3240432	Inhibition of human DAPK1 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	102.0	CHEMBL2558	Homo sapiens	Activity	%	102.0
	14663259	CHEMBL3270861	Inhibition of DAPK1 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	77.0	CHEMBL2558	Homo sapiens	INH	%	77.0
	14663260	CHEMBL3270861	Inhibition of DAPK1 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	100.0	CHEMBL2558	Homo sapiens	INH	%	100.0
	14663261	CHEMBL3270861	Inhibition of DAPK1 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	100.0	CHEMBL2558	Homo sapiens	INH	%	100.0
	15008003	CHEMBL3367996	Inhibition of human DAPK1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	12.0	CHEMBL2558	Homo sapiens	INH	%	12.0
	15008004	CHEMBL3367996	Inhibition of human DAPK1 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	0.0	CHEMBL2558	Homo sapiens	INH	%	0.0
	15008005	CHEMBL3367996	Inhibition of human DAPK1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	31.0	CHEMBL2558	Homo sapiens	INH	%	31.0
	15018571	CHEMBL3361885	Inhibition of DAPK1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	9.4	CHEMBL2558	Homo sapiens	INH	%	9.4
	15055360	CHEMBL3380492	Inhibition of DAPK1 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	15.0	CHEMBL2558	Homo sapiens	Activity	%	15.0
Not Active	15062588	CHEMBL3370301	Inhibition of human DAPK1 by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
	15072458	CHEMBL3380116	Inhibition of DAPK1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	112.0	CHEMBL2558	Homo sapiens	Activity	%	112.0
	15076221	CHEMBL3382265	Binding affinity to DAPK1 (unknown origin) at 10 uM relative to control	B	COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC		CHEMBL3334979	=	Activity	%	83.0	CHEMBL2558	Homo sapiens	Activity	%	83.0
	15076222	CHEMBL3382265	Binding affinity to DAPK1 (unknown origin) at 10 uM relative to control	B	COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3n2)cc1OC		CHEMBL3334980	=	Activity	%	77.0	CHEMBL2558	Homo sapiens	Activity	%	77.0
	15726496	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL151	=	IC50	nM	21000.0	CHEMBL2558	Homo sapiens	IC50	uM	21.0
	15726497	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	IC50	nM	31000.0	CHEMBL2558	Homo sapiens	IC50	uM	31.0
	15726498	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12	Outside typical range	CHEMBL117	>	IC50	nM	300000.0	CHEMBL2558	Homo sapiens	IC50	uM	300.0
	15726499	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	8900.0	CHEMBL2558	Homo sapiens	IC50	uM	8.9
	15726500	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL164	=	IC50	nM	23000.0	CHEMBL2558	Homo sapiens	IC50	uM	23.0
	15726501	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL150	=	IC50	nM	10000.0	CHEMBL2558	Homo sapiens	IC50	uM	10.0
Not Determined	15726502	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12		CHEMBL31574		IC50			CHEMBL2558	Homo sapiens	IC50		
	15726503	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12	Outside typical range	CHEMBL8260	=	IC50	nM	120000.0	CHEMBL2558	Homo sapiens	IC50	uM	120.0
	15726504	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12		CHEMBL28626	=	IC50	nM	1600.0	CHEMBL2558	Homo sapiens	IC50	uM	1.6
	15726505	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O)c(O)cc(O)c12		CHEMBL253570	=	IC50	nM	87000.0	CHEMBL2558	Homo sapiens	IC50	uM	87.0
	15726506	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	Oc1cc(O)c2cc(O)c(-c3ccc(O)c(O)c3)[o+]c2c1	Outside typical range	CHEMBL404515	=	IC50	nM	150000.0	CHEMBL2558	Homo sapiens	IC50	uM	150.0
	15726507	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	Oc1ccc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc1	Outside typical range	CHEMBL1197905	=	IC50	nM	220000.0	CHEMBL2558	Homo sapiens	IC50	uM	220.0
	15726508	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	IC50	nM	98000.0	CHEMBL2558	Homo sapiens	IC50	uM	98.0
Not Determined	15726509	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1		CHEMBL131921		IC50			CHEMBL2558	Homo sapiens	IC50		
	15726510	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=c1c(-c2ccc(O)c(O)c2)coc2cc(O)ccc12	Outside typical range	CHEMBL13486	=	IC50	nM	280000.0	CHEMBL2558	Homo sapiens	IC50	uM	280.0
	15726511	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2	Outside typical range	CHEMBL311498	>	IC50	nM	300000.0	CHEMBL2558	Homo sapiens	IC50	uM	300.0
	15726512	CHEMBL3620066	Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay	B	O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1	Outside typical range	CHEMBL36327	>	IC50	nM	300000.0	CHEMBL2558	Homo sapiens	IC50	uM	300.0
	15726513	CHEMBL3620067	Inhibition of DAPK1 (unknown origin) using ZIPtide as substrate by fluorescence assay in presence of ATP, MgCl2	B	O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12		CHEMBL28626	=	IC50	nM	11000.0	CHEMBL2558	Homo sapiens	IC50	uM	11.0
	15745679	CHEMBL3625484	Inhibition of recombinant DAPK1 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)c(C)s3)nc21		CHEMBL3622137	=	IC50	nM	1400.0	CHEMBL2558	Homo sapiens	IC50	uM	1.4
	15756044	CHEMBL3632429	Inhibition of DAPK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1	Outside typical range	CHEMBL3628627	=	Inhibition	%	-20.61	CHEMBL2558	Homo sapiens	INH	%	-20.61
	15757015	CHEMBL3632429	Inhibition of DAPK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1	Outside typical range	CHEMBL166031	=	Inhibition	%	-27.07	CHEMBL2558	Homo sapiens	INH	%	-27.07
	15758678	CHEMBL3632429	Inhibition of DAPK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-20.31	CHEMBL2558	Homo sapiens	INH	%	-20.31
	16379653	CHEMBL3738555	Inhibition of DAPK1 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	80.5	CHEMBL2558	Homo sapiens	INH	%	80.5
	16379654	CHEMBL3738555	Inhibition of DAPK1 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	94.9	CHEMBL2558	Homo sapiens	INH	%	94.9
	16379704	CHEMBL3736657	Inhibition of DAPK1 (unknown origin) by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	IC50	nM	12.0	CHEMBL2558	Homo sapiens	IC50	nM	12.0
	16425282	CHEMBL3751102	Inhibition of DAPK1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	0.1	CHEMBL2558	Homo sapiens	INH	%	0.1
	16431795	CHEMBL3748999	Inhibition of human DAPK1 using [KKLNRTLSFAEPG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2558	Homo sapiens	IC50	uM	10.0
	16450808	CHEMBL3762326	Inhibition of DAPK1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	2.2	CHEMBL2558	Homo sapiens	INH	%	2.2
	16495381	CHEMBL3778361	Inhibition of N-terminal His6-tagged recombinant human DAPK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	1.0	CHEMBL2558	Homo sapiens	Activity	%	1.0
	16508150	CHEMBL3778361	Inhibition of N-terminal His6-tagged recombinant human DAPK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-3.0	CHEMBL2558	Homo sapiens	Activity	%	-3.0
	16509127	CHEMBL3778361	Inhibition of N-terminal His6-tagged recombinant human DAPK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-11.0	CHEMBL2558	Homo sapiens	Activity	%	-11.0
	16559697	CHEMBL3794929	Inhibition of human N-terminal GST-tagged DAPK1 catalytic domain (1 to 289 residues) expressed in baculovirus expression system using fluorescence labelled DAPK1tide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	32.9	CHEMBL2558	Homo sapiens	INH	%	32.9
	16559698	CHEMBL3794929	Inhibition of human N-terminal GST-tagged DAPK1 catalytic domain (1 to 289 residues) expressed in baculovirus expression system using fluorescence labelled DAPK1tide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	13.0	CHEMBL2558	Homo sapiens	INH	%	13.0
	16559699	CHEMBL3794929	Inhibition of human N-terminal GST-tagged DAPK1 catalytic domain (1 to 289 residues) expressed in baculovirus expression system using fluorescence labelled DAPK1tide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	8.3	CHEMBL2558	Homo sapiens	INH	%	8.3
	16562750	CHEMBL3802096	Inhibition of DAPK1 (unknown origin)	B	O=C1Nc2ccc(NC(=O)C3CC3)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL3799389	=	IC50	nM	140.0	CHEMBL2558	Homo sapiens	IC50	uM	0.14
	16562751	CHEMBL3802096	Inhibition of DAPK1 (unknown origin)	B	CC(C)=CC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2		CHEMBL3797466	=	IC50	nM	450.0	CHEMBL2558	Homo sapiens	IC50	uM	0.45
	16562752	CHEMBL3802096	Inhibition of DAPK1 (unknown origin)	B	CC(C)(C)CC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2		CHEMBL3799505	>	IC50	nM	10000.0	CHEMBL2558	Homo sapiens	IC50	uM	10.0
	16562753	CHEMBL3802096	Inhibition of DAPK1 (unknown origin)	B	CC(C)(C)C(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2		CHEMBL513703	=	IC50	nM	700.0	CHEMBL2558	Homo sapiens	IC50	uM	0.7
	16562754	CHEMBL3802096	Inhibition of DAPK1 (unknown origin)	B	CCCCC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2		CHEMBL3797480	=	IC50	nM	1800.0	CHEMBL2558	Homo sapiens	IC50	uM	1.8
	16562755	CHEMBL3802096	Inhibition of DAPK1 (unknown origin)	B	CCCC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2		CHEMBL3799585	=	IC50	nM	510.0	CHEMBL2558	Homo sapiens	IC50	uM	0.51
	16578385	CHEMBL3802257	Inhibition of partial length wild type human DAPK1 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	16594822	CHEMBL3813085	Inhibition of DAPK (unknown origin)	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Inhibition	%	7.0	CHEMBL2558	Homo sapiens	INH	%	7.0
	16611877	CHEMBL3816741	Inhibition of human DAPK1 (1 to 363 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-28.0	CHEMBL2558	Homo sapiens	Activity	%	-28.0
	16614445	CHEMBL3817311	Inhibition of human DAPK1 at 1 uM using [KKLNRTLSFAEPG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	2.0	CHEMBL2558	Homo sapiens	INH	%	2.0
	16618243	CHEMBL3816211	Inhibition of recombinant human GST-tagged DAPK1 catalytic domain expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	16627506	CHEMBL3820222	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to 296 residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	1.0	CHEMBL2558	Homo sapiens	INH	%	1.0
	16627507	CHEMBL3820222	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to 296 residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	1.0	CHEMBL2558	Homo sapiens	INH	%	1.0
	16654151	CHEMBL3829172	Inhibition of human DAPK1 (1 to 363) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	96.0	CHEMBL2558	Homo sapiens	Activity	%	96.0
	16837431	CHEMBL3876100	Inhibition of human recombinant N-terminal GST-tagged DAPK1 catalytic domain (1 to 363 residues) expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL2558	Homo sapiens	IC50	nM	10000.0
	17964890	CHEMBL3994999	Inhibition of human DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	17978435	CHEMBL3997627	Inhibition of recombinant human N-terminal GST-tagged DAPK1 catalytic domain (1 to 289 residues) expressed in baculovirus infected sf21 cells at 200 nM using DAPK1tide as substrate by electrophoretic mobility shift assay relative to control	B	O=C1/C(=C/c2c[nH]c3nc(Cl)ccc23)Oc2c1ccc(O)c2CN1CCNCC1		CHEMBL4061176	=	Inhibition	%	57.0	CHEMBL2558	Homo sapiens	INH	%	57.0
	17978436	CHEMBL3997627	Inhibition of recombinant human N-terminal GST-tagged DAPK1 catalytic domain (1 to 289 residues) expressed in baculovirus infected sf21 cells at 200 nM using DAPK1tide as substrate by electrophoretic mobility shift assay relative to control	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(Cl)ccc13)C2=O		CHEMBL4062256	=	Inhibition	%	80.0	CHEMBL2558	Homo sapiens	INH	%	80.0
	17978437	CHEMBL3997627	Inhibition of recombinant human N-terminal GST-tagged DAPK1 catalytic domain (1 to 289 residues) expressed in baculovirus infected sf21 cells at 200 nM using DAPK1tide as substrate by electrophoretic mobility shift assay relative to control	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(F)ccc13)C2=O		CHEMBL4083975	=	Inhibition	%	97.0	CHEMBL2558	Homo sapiens	INH	%	97.0
	17978438	CHEMBL3997627	Inhibition of recombinant human N-terminal GST-tagged DAPK1 catalytic domain (1 to 289 residues) expressed in baculovirus infected sf21 cells at 200 nM using DAPK1tide as substrate by electrophoretic mobility shift assay relative to control	B	CCc1ccc2c(/C=C3\Oc4c(ccc(OC)c4CN4CCNCC4)C3=O)c[nH]c2n1		CHEMBL4074201	=	Inhibition	%	77.0	CHEMBL2558	Homo sapiens	INH	%	77.0
	17978439	CHEMBL3997627	Inhibition of recombinant human N-terminal GST-tagged DAPK1 catalytic domain (1 to 289 residues) expressed in baculovirus infected sf21 cells at 200 nM using DAPK1tide as substrate by electrophoretic mobility shift assay relative to control	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(C)ccc13)C2=O		CHEMBL4060711	=	Inhibition	%	91.0	CHEMBL2558	Homo sapiens	INH	%	91.0
	18021236	CHEMBL4005948	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to 296 amino acid residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCNCC3)cn2)n1		CHEMBL4071812	<	Inhibition	%	10.0	CHEMBL2558	Homo sapiens	INH	%	10.0
	18021237	CHEMBL4005948	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to 296 amino acid residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1nc(Nc2ccc(N3CCN(C)CC3)cn2)ncc1F		CHEMBL4072255	<	Inhibition	%	10.0	CHEMBL2558	Homo sapiens	INH	%	10.0
	18052906	CHEMBL4011918	Inhibition of DAPK1 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O	Outside typical range	CHEMBL4089159	=	Inhibition	%	-37.6	CHEMBL2558	Homo sapiens	INH	%	-37.6
	18066654	CHEMBL4014507	Inhibition of human DAPK1	B	O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21		CHEMBL490355	=	IC50	nM	13150.0	CHEMBL2558	Homo sapiens	IC50	uM	13.15
	18066655	CHEMBL4014508	Inhibition of human DAPK1 at 10 uM relative to control	B	COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC		CHEMBL3334979	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	18066656	CHEMBL4014508	Inhibition of human DAPK1 at 10 uM relative to control	B	CCOc1cc(/C=C2\Oc3ccc(OC)cc3C2=O)ccc1O		CHEMBL4105195	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	18066657	CHEMBL4014508	Inhibition of human DAPK1 at 10 uM relative to control	B	COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2		CHEMBL4087337	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	18066772	CHEMBL4014561	Binding affinity to DAPK1 (unknown origin)	B	Nc1c(-c2n[nH]c(=S)o2)sc2ncc(-c3ccsc3)cc12		CHEMBL4060481	=	Kd	nM	54.0	CHEMBL2558	Homo sapiens	Kd	nM	54.0
	18099877	CHEMBL4021784	Inhibition of DAPK1 (unknown origin)	B	Cc1ccc(CNc2nc(N)nc3[nH]c4cc(C)c(O)cc4c23)cc1		CHEMBL4098682	>	IC50	nM	100000.0	CHEMBL2558	Homo sapiens	IC50	uM	100.0
	18114410	CHEMBL4025084	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	18135434	CHEMBL4029687	Inhibition of partial length wild type human DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1cscn1		CHEMBL4061891	=	Activity	%	92.0	CHEMBL2558	Homo sapiens	Activity	%	92.0
	18135451	CHEMBL4029687	Inhibition of partial length wild type human DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1csc(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4075290	=	Activity	%	102.0	CHEMBL2558	Homo sapiens	Activity	%	102.0
	18135468	CHEMBL4029687	Inhibition of partial length wild type human DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)N2C(=O)C3Nc4cc(Cl)cc(Cl)c4C3C=C12		CHEMBL4096175	=	Activity	%	90.0	CHEMBL2558	Homo sapiens	Activity	%	90.0
	18135485	CHEMBL4029687	Inhibition of partial length wild type human DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	N=C1NC(=O)/C(=C/c2csc(-c3ccc(C(F)(F)F)cc3)n2)S1		CHEMBL4064860	=	Activity	%	103.0	CHEMBL2558	Homo sapiens	Activity	%	103.0
	18203608	CHEMBL4043895	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	18232195	CHEMBL4050311	Inhibition of human DAPK1 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	50.0	CHEMBL2558	Homo sapiens	Activity	%	50.0
	18234339	CHEMBL4050784	Inhibition of human DAPK1 using KKLNRTLSFAEPG as substrate in presence of [gamma-33P]-ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	9.4	CHEMBL2558	Homo sapiens	IC50	nM	9.4
	18234353	CHEMBL4050770	Activation of human DAPK1 using KKLNRTLSFAEPG as substrate in presence of [gamma-33P]-ATP	B	O=C(COc1cccc2ccccc12)Nc1cccc(C(=O)O)c1		CHEMBL4088576	=	EC50	nM	39525.0	CHEMBL2558	Homo sapiens	EC50	uM	39.525
	18253349	CHEMBL4054958	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	63.0	CHEMBL2558	Homo sapiens	Activity	%	63.0
	18253350	CHEMBL4054958	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL2558	Homo sapiens	Activity	%	96.0
	18265826	CHEMBL4057276	Inhibition of DAPK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.3	CHEMBL2558	Homo sapiens	INH	%	-1.3
	18266086	CHEMBL4057536	Inhibition of DAPK1 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-2.7	CHEMBL2558	Homo sapiens	INH	%	-2.7
	18282010	CHEMBL4119965	Inhibition of recombinant N-terminal GST-tagged human DAPK1 (1 to 363 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	-5.1	CHEMBL2558	Homo sapiens	INH	%	-5.1
	18282329	CHEMBL4119965	Inhibition of recombinant N-terminal GST-tagged human DAPK1 (1 to 363 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	14.0	CHEMBL2558	Homo sapiens	INH	%	14.0
	18282848	CHEMBL4120433	Inhibition of DAPK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.3	CHEMBL2558	Homo sapiens	INH	%	-1.3
	18283068	CHEMBL4120653	Inhibition of DAPK1 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1	Outside typical range	CHEMBL4125807	=	Inhibition	%	-14.3	CHEMBL2558	Homo sapiens	INH	%	-14.3
	18283288	CHEMBL4120873	Inhibition of DAPK1 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-3.7	CHEMBL2558	Homo sapiens	INH	%	-3.7
	18379909	CHEMBL4145811	Inhibition of DAPK1 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	4.75	CHEMBL2558	Homo sapiens	INH	%	4.75
	18379961	CHEMBL4145862	Inhibition of DAPK1 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	13.08	CHEMBL2558	Homo sapiens	IC50	nM	13.08
	18407901	CHEMBL4151457	Inhibition of human DAPK1 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	85.0	CHEMBL2558	Homo sapiens	Activity	%	85.0
	18407942	CHEMBL4151457	Inhibition of human DAPK1 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12		CHEMBL4173266	=	Activity	%	8.8	CHEMBL2558	Homo sapiens	Activity	%	8.8
	18407987	CHEMBL4151457	Inhibition of human DAPK1 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	78.0	CHEMBL2558	Homo sapiens	Activity	%	78.0
	18440150	CHEMBL4156974	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	97.0	CHEMBL2558	Homo sapiens	Activity	%	97.0
	18449494	CHEMBL4177941	Inhibition of DAPK1 (unknown origin) at 1 uM	B	CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccc(F)cc1Br		CHEMBL3742114	=	Inhibition	%	3.0	CHEMBL2558	Homo sapiens	INH	%	3.0
	18449909	CHEMBL4178145	Inhibition of human DAPK1 (1 to 363 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	96.0	CHEMBL2558	Homo sapiens	Activity	%	96.0
	18450293	CHEMBL4178285	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to363 residues) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	2.0	CHEMBL2558	Homo sapiens	Activity	%	2.0
	18450343	CHEMBL4178285	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to363 residues) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-1.0	CHEMBL2558	Homo sapiens	Activity	%	-1.0
	18470579	CHEMBL4182573	Inhibition of human DAPK1 at 10 uM by ADP-Glo kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	86.0	CHEMBL2558	Homo sapiens	INH	%	86.0
	18470749	CHEMBL4182573	Inhibition of human DAPK1 at 10 uM by ADP-Glo kinase assay	B	Cc1nc(N)c2ccn(C3CCN(C(=O)c4ccc(S(=O)(=O)F)cc4)CC3)c2n1		CHEMBL4206295	=	Inhibition	%	13.0	CHEMBL2558	Homo sapiens	INH	%	13.0
	18470750	CHEMBL4182573	Inhibition of human DAPK1 at 10 uM by ADP-Glo kinase assay	B	Nc1ncnc2c1ccn2C1CCN(C(=O)c2ccc(S(=O)(=O)F)cc2)CC1		CHEMBL4218073	=	Inhibition	%	4.0	CHEMBL2558	Homo sapiens	INH	%	4.0
	18484590	CHEMBL4185753	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	90.0	CHEMBL2558	Homo sapiens	Activity	%	90.0
	18485031	CHEMBL4185753	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	18507828	CHEMBL4190934	Inhibition of recombinant human DAPK1 (1 to 296 residues) at 1 uM using KKLNRTLSFAEPG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-2.0	CHEMBL2558	Homo sapiens	INH	%	-2.0
	18653687	CHEMBL4230060	Inhibition of DAPK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-2.0	CHEMBL2558	Homo sapiens	INH	%	-2.0
	18653688	CHEMBL4230060	Inhibition of DAPK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-2.0	CHEMBL2558	Homo sapiens	INH	%	-2.0
	18655582	CHEMBL4230653	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	96.0	CHEMBL2558	Homo sapiens	Activity	%	96.0
	18665542	CHEMBL4233310	Inhibition of DAPK1 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL2558	Homo sapiens	IC50	nM	1000.0
	18674619	CHEMBL4235340	Inhibition of DAPK1 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL2558	Homo sapiens	Ki	nM	2000.0
	18674620	CHEMBL4235340	Inhibition of DAPK1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2558	Homo sapiens	Ki	nM	2000.0
Not Determined	18674621	CHEMBL4235340	Inhibition of DAPK1 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL2558	Homo sapiens	Ki		
	18697625	CHEMBL4254298	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	93.0	CHEMBL2558	Homo sapiens	Activity	%	93.0
	18725380	CHEMBL4259077	Inhibition of DAPK1 (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL2558	Homo sapiens	IC50	uM	100.0
	18751137	CHEMBL4263777	Inhibition of DAPK1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	1.0	CHEMBL2558	Homo sapiens	INH	%	1.0
	18751661	CHEMBL4264242	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	80.0	CHEMBL2558	Homo sapiens	Activity	%	80.0
	18764671	CHEMBL4267126	Inhibition of human DAPK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL2558	Homo sapiens	INH	%	70.0
Not Determined	18764672	CHEMBL4267126	Inhibition of human DAPK1 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Not Determined	18764673	CHEMBL4267126	Inhibition of human DAPK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
	18857911	CHEMBL4307757	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	18892600	CHEMBL4314701	Inhibition of recombinant human DAPK1 (1 to 296 residues) assessed as residual activity at 10 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	114.5	CHEMBL2558	Homo sapiens	Activity	%	114.5
	18919508	CHEMBL4322865	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged DAPK1 (unknown origin) (1 to 289 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	69.0	CHEMBL2558	Homo sapiens	Kd	nM	69.0
	18919696	CHEMBL4322865	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged DAPK1 (unknown origin) (1 to 289 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	59.0	CHEMBL2558	Homo sapiens	Kd	nM	59.0
	18929794	CHEMBL4325346	Inhibition of recombinant human N-terminal GST-tagged DAPK1 catalytic domain (1 to 363 residues) expressed in baculovirus expression system by Adapta kinase assay	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133	=	IC50	nM	203.0	CHEMBL2558	Homo sapiens	IC50	nM	203.0
	18929809	CHEMBL4325361	Inhibition of recombinant human N-terminal GST-tagged DAPK1 catalytic domain (1 to 363 residues) expressed in baculovirus expression system at 1000 nM by Adapta kinase assay relative to control	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133	=	Inhibition	%	85.0	CHEMBL2558	Homo sapiens	INH	%	85.0
	18934091	CHEMBL4326623	Inhibition of human DAPK1 at 10 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	42.2	CHEMBL2558	Homo sapiens	INH	%	42.2
	18937851	CHEMBL4327656	Inhibition of human DAPK1 assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	119.19	CHEMBL2558	Homo sapiens	Activity	%	119.19
	18937852	CHEMBL4327656	Inhibition of human DAPK1 assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	104.75	CHEMBL2558	Homo sapiens	Activity	%	104.75
	18938496	CHEMBL4328016	Inhibition of human DAPK1 assessed as residual activity at 100 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2558	Homo sapiens	Activity	%	65.0
	18938873	CHEMBL4328380	Inhibition of human DAPK1 using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	15.7	CHEMBL2558	Homo sapiens	IC50	10'-8M	1.57
	18958828	CHEMBL4333347	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	18964218	CHEMBL4335046	Inhibition of recombinant human DAPK1 (1 to 296 residues) assessed as residual activity at 1 uM KKLNRTLSFAEPG as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	84.0	CHEMBL2558	Homo sapiens	Activity	%	84.0
	18964219	CHEMBL4335046	Inhibition of recombinant human DAPK1 (1 to 296 residues) assessed as residual activity at 1 uM KKLNRTLSFAEPG as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	92.0	CHEMBL2558	Homo sapiens	Activity	%	92.0
	18971864	CHEMBL4336874	Inhibition of recombinant human DAPK1 (1 to 296 residues) assessed as residual activity at 10 uM KKLNRTLSFAEPG as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	84.0	CHEMBL2558	Homo sapiens	Activity	%	84.0
	19035298	CHEMBL4350394	Inhibition of human DAPK1 assessed as residual activity at 10 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	87.0	CHEMBL2558	Homo sapiens	Activity	%	87.0
Not Active	19039817	CHEMBL4351825	Inhibition of recombinant human DAPK1 (1 to 296 residues) at 10 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	19041074	CHEMBL4352335	Inhibition of human DAPK1 at 10 uM using KKLNRTLSFAEPG as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
	19059530	CHEMBL4357831	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	19090101	CHEMBL4365675	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	19091889	CHEMBL4366363	Inhibition of human DAPK1 at 100 nM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-25.21	CHEMBL2558	Homo sapiens	INH	%	-25.21
	19144767	CHEMBL4377783	Inhibition of recombinant human DAPK1 (1 to 296 residues) at 1 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-5.0	CHEMBL2558	Homo sapiens	INH	%	-5.0
	19146902	CHEMBL4378890	Inhibition of recombinant human DAPK1 (1 to 296 residues) at 10 uM using KKLNRTLSFAEPG as substrate after 40 mins by in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	8.0	CHEMBL2558	Homo sapiens	INH	%	8.0
	19147815	CHEMBL4379211	Inhibition of recombinant human DAPK1 (1 to 296 residues) using KKLNRTLSFAEPG as substrate incubated 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2558	Homo sapiens	IC50	uM	10.0
	19159358	CHEMBL4382462	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	59.0	CHEMBL2558	Homo sapiens	Activity	%	59.0
	19163588	CHEMBL4383831	Inhibition of human DAPK1 (1 to 363 residues) at 10 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(N)=O)c1		CHEMBL4522113	=	Inhibition	%	15.83	CHEMBL2558	Homo sapiens	INH	%	15.83
	19163589	CHEMBL4383831	Inhibition of human DAPK1 (1 to 363 residues) at 10 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(F)cc3)ncc2NC(N)=O)cc1		CHEMBL4434760	=	Inhibition	%	17.11	CHEMBL2558	Homo sapiens	INH	%	17.11
	19163590	CHEMBL4383831	Inhibition of human DAPK1 (1 to 363 residues) at 10 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(N)=O)cc1		CHEMBL4443393	=	Inhibition	%	19.71	CHEMBL2558	Homo sapiens	INH	%	19.71
	19163591	CHEMBL4383831	Inhibition of human DAPK1 (1 to 363 residues) at 10 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(N4CCCCC4)nc3)ncc2NC(N)=O)cc1		CHEMBL4587860	=	Inhibition	%	31.71	CHEMBL2558	Homo sapiens	INH	%	31.71
	19163592	CHEMBL4383831	Inhibition of human DAPK1 (1 to 363 residues) at 10 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cccc(OC)c2)cc1		CHEMBL4568513	=	Inhibition	%	75.06	CHEMBL2558	Homo sapiens	INH	%	75.06
	19163593	CHEMBL4383831	Inhibition of human DAPK1 (1 to 363 residues) at 10 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(N4CCCCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461940	=	Inhibition	%	67.28	CHEMBL2558	Homo sapiens	INH	%	67.28
	19163594	CHEMBL4383831	Inhibition of human DAPK1 (1 to 363 residues) at 10 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(F)cc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4521651	=	Inhibition	%	65.0	CHEMBL2558	Homo sapiens	INH	%	65.0
	19163595	CHEMBL4383831	Inhibition of human DAPK1 (1 to 363 residues) at 10 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911	=	Inhibition	%	66.22	CHEMBL2558	Homo sapiens	INH	%	66.22
Not Determined	19163596	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(N)=O)cc1		CHEMBL4585766		IC50			CHEMBL2558	Homo sapiens	IC50		
	19163597	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	NC(=O)Nc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1Oc1ccc(C(F)(F)F)cc1		CHEMBL4459764	=	IC50	nM	14300.0	CHEMBL2558	Homo sapiens	IC50	uM	14.3
Not Determined	19163598	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(N)=O)c1		CHEMBL4522113		IC50			CHEMBL2558	Homo sapiens	IC50		
Not Determined	19163599	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(F)cc3)ncc2NC(N)=O)cc1		CHEMBL4434760		IC50			CHEMBL2558	Homo sapiens	IC50		
Not Determined	19163600	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(N)=O)cc1		CHEMBL4443393		IC50			CHEMBL2558	Homo sapiens	IC50		
Not Determined	19163601	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCCCC4)nc3)ncc2NC(N)=O)cc1		CHEMBL4587860		IC50			CHEMBL2558	Homo sapiens	IC50		
	19163602	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cccc(C(F)(F)F)c2)cc1		CHEMBL4467582	=	IC50	nM	2610.0	CHEMBL2558	Homo sapiens	IC50	uM	2.61
	19163603	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4464585	=	IC50	nM	2770.0	CHEMBL2558	Homo sapiens	IC50	uM	2.77
	19163604	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cccc(OC)c2)cc1		CHEMBL4568513	=	IC50	nM	7440.0	CHEMBL2558	Homo sapiens	IC50	uM	7.44
	19163605	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCCCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461940	=	IC50	nM	2690.0	CHEMBL2558	Homo sapiens	IC50	uM	2.69
	19163606	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(F)cc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4521651	=	IC50	nM	4290.0	CHEMBL2558	Homo sapiens	IC50	uM	4.29
	19163607	CHEMBL4383832	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911	=	IC50	nM	1250.0	CHEMBL2558	Homo sapiens	IC50	uM	1.25
	19163608	CHEMBL4383833	Inhibition of human DAPK1 (1 to 363 residues) at 20 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(N)=O)cc1		CHEMBL4585766	=	Inhibition	%	10.79	CHEMBL2558	Homo sapiens	INH	%	10.79
	19163609	CHEMBL4383833	Inhibition of human DAPK1 (1 to 363 residues) at 20 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	NC(=O)Nc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1Oc1ccc(C(F)(F)F)cc1		CHEMBL4459764	=	Inhibition	%	44.91	CHEMBL2558	Homo sapiens	INH	%	44.91
	19163610	CHEMBL4383833	Inhibition of human DAPK1 (1 to 363 residues) at 20 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cccc(C(F)(F)F)c2)cc1		CHEMBL4467582	=	Inhibition	%	69.7	CHEMBL2558	Homo sapiens	INH	%	69.7
	19163611	CHEMBL4383833	Inhibition of human DAPK1 (1 to 363 residues) at 20 uM using KKLNRTLSFAEPG as substrate after 120 mins in presence of 10 uM [gamma-33P]-ATP by filtration method relative to control	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4464585	=	Inhibition	%	65.95	CHEMBL2558	Homo sapiens	INH	%	65.95
	19163612	CHEMBL4383834	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 1 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911	=	IC50	nM	2894.0	CHEMBL2558	Homo sapiens	IC50	uM	2.894
	19163613	CHEMBL4383835	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins in presence of 100 uM [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911	=	IC50	nM	920.0	CHEMBL2558	Homo sapiens	IC50	uM	0.92
	19163614	CHEMBL4383836	Inhibition of human DAPK1 (1 to 363 residues) using KKLNRTLSFAEPG as substrate after 120 mins [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911	=	Ki	nM	581.0	CHEMBL2558	Homo sapiens	Ki	uM	0.581
Not Active	19163618	CHEMBL4383840	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 1 to 50 uM after 48 hrs by Hoechst staining based HCS analysis	B	NC(=O)Nc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1Oc1ccc(C(F)(F)F)cc1		CHEMBL4459764		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Not Active	19163619	CHEMBL4383840	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 1 to 50 uM after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cccc(C(F)(F)F)c2)cc1		CHEMBL4467582		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	19163620	CHEMBL4383841	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 50 uM after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4464585		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	19163621	CHEMBL4383841	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 50 uM after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cccc(OC)c2)cc1		CHEMBL4568513		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	19163622	CHEMBL4383841	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 50 uM after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(N4CCCCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461940		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	19163623	CHEMBL4383841	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 50 uM after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(F)cc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4521651		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	19163624	CHEMBL4383841	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 50 uM after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Not Active	19163625	CHEMBL4383842	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 10 uM after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4464585		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Not Active	19163626	CHEMBL4383842	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 10 uM after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(F)cc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4521651		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
Active	19163627	CHEMBL4383842	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 10 uM after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
	19163628	CHEMBL4383843	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation at 16 uM after 48 hrs by Hoechst staining based HCS analysis relative to control	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911	=	Inhibition	%	100.0	CHEMBL2558	Homo sapiens	INH	%	100.0
	19163629	CHEMBL4383844	Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation after 48 hrs by Hoechst staining based HCS analysis	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911	=	IC50	nM	5000.0	CHEMBL2558	Homo sapiens	IC50	uM	5.0
	19181009	CHEMBL4387220	Inhibition of recombinant human GST-tagged DAPK1 catalytic domain (1 to 363 residues) expressed in baculovirus expression system at 0.1 uM using ZIPtide peptide as substrate incubated for 60 mins by Adapta assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	31.2	CHEMBL2558	Homo sapiens	INH	%	31.2
	19181235	CHEMBL4387220	Inhibition of recombinant human GST-tagged DAPK1 catalytic domain (1 to 363 residues) expressed in baculovirus expression system at 0.1 uM using ZIPtide peptide as substrate incubated for 60 mins by Adapta assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	14.0	CHEMBL2558	Homo sapiens	INH	%	14.0
	19191649	CHEMBL4389181	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	4.0	CHEMBL2558	Homo sapiens	INH	%	4.0
	19191844	CHEMBL4389658	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	5.3	CHEMBL2558	Homo sapiens	INH	%	5.3
	19199938	CHEMBL4391284	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	68.0	CHEMBL2558	Homo sapiens	Activity	%	68.0
	19266385	CHEMBL4405335	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2558	Homo sapiens	INH	%	50.0
	19275970	CHEMBL4407973	Inhibition of recombinant human DAPK1 (1 to 296 residues) at 1 uM using KKLNRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL2558	Homo sapiens	INH	%	0.0
	19294319	CHEMBL4412076	Inhibition of human DAPK1 assessed as enzyme activity at 30 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	O=C1C=CC2(C=C1)OCC(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)N2c1ccccc1		CHEMBL4476753	=	Activity	%	45.32	CHEMBL2558	Homo sapiens	Activity	%	45.32
	19294335	CHEMBL4412092	Inhibition of human DAPK1 using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	13.1	CHEMBL2558	Homo sapiens	IC50	10'-8M	1.31
Not Active	19296720	CHEMBL4412656	Inhibition of DAPK1 (unknown origin) at 10 uM after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(Cn2cc(C(=O)N/N=C3/C(=O)Nc4c(C)cccc43)nn2)cc1		CHEMBL4529234		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
	19476565	CHEMBL4479713	Inhibition of recombinant human GST-tagged DAPK1 catalytic domain expressed in baculovirus expression system by Adapta assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	<	IC50	nM	10.0	CHEMBL2558	Homo sapiens	IC50	nM	10.0
	19476665	CHEMBL4479713	Inhibition of recombinant human GST-tagged DAPK1 catalytic domain expressed in baculovirus expression system by Adapta assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	<	IC50	nM	10.0	CHEMBL2558	Homo sapiens	IC50	nM	10.0
	19476765	CHEMBL4479713	Inhibition of recombinant human GST-tagged DAPK1 catalytic domain expressed in baculovirus expression system by Adapta assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	1.9	CHEMBL2558	Homo sapiens	IC50	nM	1.9
	19476865	CHEMBL4479713	Inhibition of recombinant human GST-tagged DAPK1 catalytic domain expressed in baculovirus expression system by Adapta assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	26.0	CHEMBL2558	Homo sapiens	IC50	nM	26.0
	20600502	CHEMBL4603454	Inhibition of recombinant human GST-tagged DAPK1 catalytic domain (1 to 363 residues) expressed in baculovirus expression system using ZIPtide peptide as substrate incubated for 60 mins in presence of ATP by Adapta assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2558	Homo sapiens	IC50	uM	100.0
	20714400	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL1835063	=	Delta Tm	degrees C	5.92	CHEMBL2558	Homo sapiens	deltaTm	degrees C	5.92
	20714401	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4639597	=	Delta Tm	degrees C	6.07	CHEMBL2558	Homo sapiens	deltaTm	degrees C	6.07
	20714402	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CC(C)(C)c1cccc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)c1		CHEMBL4632574	=	Delta Tm	degrees C	3.02	CHEMBL2558	Homo sapiens	deltaTm	degrees C	3.02
	20714403	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CS(=O)(=O)c1cccc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)c1		CHEMBL4640445	=	Delta Tm	degrees C	4.21	CHEMBL2558	Homo sapiens	deltaTm	degrees C	4.21
	20714404	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cccc(-c2ccccc2)c1		CHEMBL4644948	=	Delta Tm	degrees C	4.81	CHEMBL2558	Homo sapiens	deltaTm	degrees C	4.81
	20714405	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CC(C)(C#N)c1cccc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)c1		CHEMBL4640492	=	Delta Tm	degrees C	3.32	CHEMBL2558	Homo sapiens	deltaTm	degrees C	3.32
	20714406	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CC(C)(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)(C)C)c1		CHEMBL4648967	=	Delta Tm	degrees C	1.13	CHEMBL2558	Homo sapiens	deltaTm	degrees C	1.13
	20714407	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CC(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)C)c1		CHEMBL4634851	=	Delta Tm	degrees C	4.65	CHEMBL2558	Homo sapiens	deltaTm	degrees C	4.65
	20714408	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CC(C)(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(S(C)(=O)=O)c1		CHEMBL4632457	=	Delta Tm	degrees C	3.83	CHEMBL2558	Homo sapiens	deltaTm	degrees C	3.83
	20714409	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CC(C)(C#N)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(-c2ccccc2)c1		CHEMBL4633229	=	Delta Tm	degrees C	4.8	CHEMBL2558	Homo sapiens	deltaTm	degrees C	4.8
	20714410	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CC(C)(C#N)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)(C)C#N)c1		CHEMBL4640712	=	Delta Tm	degrees C	3.46	CHEMBL2558	Homo sapiens	deltaTm	degrees C	3.46
	20714411	CHEMBL4629887	Binding affinity to DAPK1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CC(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)C)n1		CHEMBL4635883	=	Delta Tm	degrees C	5.25	CHEMBL2558	Homo sapiens	deltaTm	degrees C	5.25
	20714453	CHEMBL4629893	Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)(C)C)c1		CHEMBL4648967	=	Activity	%	81.0	CHEMBL2558	Homo sapiens	Activity	%	81.0
	22391650	CHEMBL4666956	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to 363 residues) expressed in baculovirus expression system using ZIPtide as substrate at 0.1 uM incubated for 60 mins by Adapta assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	19.0	CHEMBL2558	Homo sapiens	INH	%	19.0
	22391651	CHEMBL4666956	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to 363 residues) expressed in baculovirus expression system using ZIPtide as substrate at 0.1 uM incubated for 60 mins by Adapta assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	11.0	CHEMBL2558	Homo sapiens	INH	%	11.0
	22391652	CHEMBL4666956	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to 363 residues) expressed in baculovirus expression system using ZIPtide as substrate at 0.1 uM incubated for 60 mins by Adapta assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	22.0	CHEMBL2558	Homo sapiens	INH	%	22.0
	22392036	CHEMBL4667131	Inhibition of recombinant human N-terminal GST-tagged DAPK1 (1 to 363 residues) expressed in baculovirus expression system using ZIPtide as substrate at 10 uM incubated for 60 mins by Adapta assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.5	CHEMBL2558	Homo sapiens	INH	%	0.5
	22423691	CHEMBL4674421	Inhibition of human DAPK1 using KKLNRTLSFAEPG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	109.75	CHEMBL2558	Homo sapiens	Activity	%	109.75
	22423692	CHEMBL4674421	Inhibition of human DAPK1 using KKLNRTLSFAEPG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	98.66	CHEMBL2558	Homo sapiens	Activity	%	98.66
	22482649	CHEMBL4687855	Inhibition of human DAPK1 assessed as residual activity at 10 uM relative to control	A	CN1CCC(CNC2=NC(=O)/C(=C/c3csc(-c4ccc(OC(F)(F)F)cc4)n3)S2)CC1		CHEMBL4757567	=	Activity	%	29.0	CHEMBL2558	Homo sapiens	Activity	%	29.0
	22482666	CHEMBL4687872	Inhibition of human DAPK1	A	CN1CCC(CNC2=NC(=O)/C(=C/c3csc(-c4ccc(OC(F)(F)F)cc4)n3)S2)CC1		CHEMBL4757567	=	IC50	nM	8950.0	CHEMBL2558	Homo sapiens	IC50	nM	8950.0
	22775413	CHEMBL4705522	Inhibition of human DAPK1	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	=	IC50	nM	23.0	CHEMBL2558	Homo sapiens	IC50	nM	23.0
	22843783	CHEMBL4720769	Inhibition of human DAPK1 using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.88	CHEMBL2558	Homo sapiens	IC50	10^-9M	8.88
	22844136	CHEMBL4721122	Inhibition of human DAPK1 assessed as residual activity using KKLNRTLSFAEPG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	88.16	CHEMBL2558	Homo sapiens	Activity	%	88.16
	22844678	CHEMBL4721353	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	64.86	CHEMBL2558	Homo sapiens	Activity	%	64.86
Not Active	22936039	CHEMBL4739736	Inhibition of human DAPK1 at 1 uM using substrate peptide by off-chip mobility shift assay	B	CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1		CHEMBL4749965		Inhibition	%		CHEMBL2558	Homo sapiens	INH		
	22943993	CHEMBL4742513	Inhibition of DAPK1 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	B	COCc1cc(C)nc2sc(C(N)=O)c(N)c12		CHEMBL4780986	=	Activity	%	84.0	CHEMBL2558	Homo sapiens	Activity	%	84.0
	22952808	CHEMBL4766745	Inhibition of recombinant human DAPK1 (1 to 296 residues) assessed as residual activity at 10 uM KKLNRTLSFAEPG as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	22989358	CHEMBL4774938	Inhibition of DAPK1 (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2cccc(C#Cc3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)c12		CHEMBL4793906	<	Inhibition	%	30.0	CHEMBL2558	Homo sapiens	INH	%	30.0
	23122516	CHEMBL4804867	Inhibition of human DAPK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL2558	Homo sapiens	Activity	%	100.0
	23123211	CHEMBL4805455	Inhibition of human DAPK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	99.0	CHEMBL2558	Homo sapiens	Activity	%	99.0
	23123680	CHEMBL4805924	Inhibition of DNA-tagged human DAPK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	86.0	CHEMBL2558	Homo sapiens	Activity	%	86.0
	23124512	CHEMBL4806472	Inhibition of human DAPK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL2558	Homo sapiens	Activity	%	92.0
	23124513	CHEMBL4806472	Inhibition of human DAPK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	88.0	CHEMBL2558	Homo sapiens	Activity	%	88.0
	23127996	CHEMBL4807807	Inhibition of DAPK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2558	Homo sapiens	Activity	%	75.0
	23127997	CHEMBL4807807	Inhibition of DAPK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2558	Homo sapiens	Activity	%	75.0
	23127998	CHEMBL4807807	Inhibition of DAPK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2558	Homo sapiens	Activity	%	75.0
	23195913	CHEMBL4819728	Inhibition of wild-type human partial length DAPK1 (M1 to F296 residues) using KKLNRTLSFAEPG peptide as substrate at 100 nM by direct-filter Binding radiometric assay relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)C4CCCCC4)CC3)c2n1		CHEMBL4875028	=	Inhibition	%	85.0	CHEMBL2558	Homo sapiens	INH	%	85.0
Not Active	23317351	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23317819	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	97.0	CHEMBL2558	Homo sapiens	% Control	%	97.0
Not Active	23318489	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	84.0	CHEMBL2558	Homo sapiens	% Control	%	84.0
Not Active	23318969	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23319608	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23320081	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	82.8	CHEMBL2558	Homo sapiens	% Control	%	82.8
Not Active	23320759	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23321227	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23321857	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	90.0	CHEMBL2558	Homo sapiens	% Control	%	90.0
Not Active	23322325	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	83.0	CHEMBL2558	Homo sapiens	% Control	%	83.0
Not Active	23323014	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	99.0	CHEMBL2558	Homo sapiens	% Control	%	99.0
Not Active	23323482	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23323985	CHEMBL4880604	DAPK1 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	0.0	CHEMBL2558	Homo sapiens	% inhibition	%	0.0
Not Active	23324336	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23324971	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	89.0	CHEMBL2558	Homo sapiens	% Control	%	89.0
Not Active	23325439	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23326086	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	90.0	CHEMBL2558	Homo sapiens	% Control	%	90.0
Not Active	23326554	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	98.0	CHEMBL2558	Homo sapiens	% Control	%	98.0
Not Active	23327254	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23327722	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23328309	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	86.0	CHEMBL2558	Homo sapiens	% Control	%	86.0
Not Active	23328777	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23329312	CHEMBL4881019	DAPK1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	109.0	CHEMBL2558	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23329723	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23330191	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	95.0	CHEMBL2558	Homo sapiens	% Control	%	95.0
Not Active	23330947	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	92.0	CHEMBL2558	Homo sapiens	% Control	%	92.0
Not Active	23331415	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23332002	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	94.1	CHEMBL2558	Homo sapiens	% Control	%	94.1
Not Active	23332470	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23333186	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	93.8	CHEMBL2558	Homo sapiens	% Control	%	93.8
Not Active	23333825	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	99.0	CHEMBL2558	Homo sapiens	% Control	%	99.0
Not Active	23334293	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23335272	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	98.0	CHEMBL2558	Homo sapiens	% Control	%	98.0
Not Active	23335740	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23336367	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	93.0	CHEMBL2558	Homo sapiens	% Control	%	93.0
Not Active	23336835	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	95.0	CHEMBL2558	Homo sapiens	% Control	%	95.0
Not Active	23337562	CHEMBL4881933	DAPK1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	99.5	CHEMBL2558	Homo sapiens	% Ctrl	%	99.5
Not Active	23337916	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	82.0	CHEMBL2558	Homo sapiens	% Control	%	82.0
Not Active	23338384	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23338996	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	92.0	CHEMBL2558	Homo sapiens	% Control	%	92.0
Active	23339464	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	0.0	CHEMBL2558	Homo sapiens	% Control	%	0.0
Not Active	23340101	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	83.0	CHEMBL2558	Homo sapiens	% Control	%	83.0
Not Active	23340569	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23341226	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23341694	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23342310	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	96.0	CHEMBL2558	Homo sapiens	% Control	%	96.0
Not Active	23342778	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23343408	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	84.0	CHEMBL2558	Homo sapiens	% Control	%	84.0
Not Active	23343876	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	97.0	CHEMBL2558	Homo sapiens	% Control	%	97.0
Not Active	23344514	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23345087	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23345555	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	83.0	CHEMBL2558	Homo sapiens	% Control	%	83.0
Not Active	23346132	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23346601	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23347209	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	90.5	CHEMBL2558	Homo sapiens	% Control	%	90.5
Not Active	23347692	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23348271	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23348739	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	80.0	CHEMBL2558	Homo sapiens	% Control	%	80.0
Not Active	23349326	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	95.0	CHEMBL2558	Homo sapiens	% Control	%	95.0
Not Active	23349944	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	99.0	CHEMBL2558	Homo sapiens	% Control	%	99.0
Not Active	23350412	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	79.0	CHEMBL2558	Homo sapiens	% Control	%	79.0
Not Active	23351017	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23351485	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23352013	CHEMBL4882704	DAPK1 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-0.6452	CHEMBL2558	Homo sapiens	% Inhibition	%	-0.6452
Not Active	23352509	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	93.0	CHEMBL2558	Homo sapiens	% Control	%	93.0
Not Active	23352977	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23353859	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23354327	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23355059	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23355527	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23356163	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23356631	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23357240	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	97.0	CHEMBL2558	Homo sapiens	% Control	%	97.0
Not Active	23357887	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23358355	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	98.0	CHEMBL2558	Homo sapiens	% Control	%	98.0
Not Active	23358941	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23359539	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23360007	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23360592	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	96.0	CHEMBL2558	Homo sapiens	% Control	%	96.0
Not Active	23361060	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23361633	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	89.0	CHEMBL2558	Homo sapiens	% Control	%	89.0
Not Active	23362169	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	99.0	CHEMBL2558	Homo sapiens	% Control	%	99.0
Not Active	23362637	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23363326	CHEMBL4883279	DAPK1 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-6.43	CHEMBL2558	Homo sapiens	% inhibition	%	-6.4301
Not Active	23363327	CHEMBL4883279	DAPK1 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-4.417	CHEMBL2558	Homo sapiens	% inhibition	%	-4.417
Not Active	23364279	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	73.0	CHEMBL2558	Homo sapiens	% Control	%	73.0
Not Active	23364747	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23365486	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	91.0	CHEMBL2558	Homo sapiens	% Control	%	91.0
Not Active	23366029	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23366619	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	92.0	CHEMBL2558	Homo sapiens	% Control	%	92.0
Not Active	23367087	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23367527	CHEMBL4883880	DAPK1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	86.0	CHEMBL2558	Homo sapiens	% Residual activity with Skepinone-L	%	86.0
Not Active	23367965	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	78.0	CHEMBL2558	Homo sapiens	% Control	%	78.0
Not Active	23368433	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	87.0	CHEMBL2558	Homo sapiens	% Control	%	87.0
Not Active	23369032	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	93.0	CHEMBL2558	Homo sapiens	% Control	%	93.0
Not Active	23369500	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23370034	CHEMBL4884278	DAPK1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	100.0	CHEMBL2558	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23370468	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23370936	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	89.0	CHEMBL2558	Homo sapiens	% Control	%	89.0
Not Active	23371745	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	88.0	CHEMBL2558	Homo sapiens	% Control	%	88.0
Not Active	23372213	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	92.0	CHEMBL2558	Homo sapiens	% Control	%	92.0
	23372716	CHEMBL4884681	DAPK1(DAP1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2558	Homo sapiens	pIC50		6.0
	23373125	CHEMBL4884972	DAPK1(DAP1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2558	Homo sapiens	pIC50		6.0
	23373486	CHEMBL4885263	DAPK1(DAP1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2558	Homo sapiens	pIC50		6.0
Not Active	23374956	CHEMBL4885950	DAPK1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	5.5	CHEMBL2558	Homo sapiens	% Inhibition	%	5.5
Not Active	23375227	CHEMBL4886209	death-associated protein kinase 1 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-2.0	CHEMBL2558	Homo sapiens	% inhibition	%	-2.0
Not Active	23375640	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	90.0	CHEMBL2558	Homo sapiens	% Control	%	90.0
Not Active	23376108	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23376685	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23377155	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23378013	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	96.0	CHEMBL2558	Homo sapiens	% Control	%	96.0
Not Active	23378481	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23379648	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23380116	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	89.0	CHEMBL2558	Homo sapiens	% Control	%	89.0
Not Active	23380810	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23381458	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23381926	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2558	Homo sapiens	% Control	%	100.0
Not Active	23382550	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	82.0	CHEMBL2558	Homo sapiens	% Control	%	82.0
Active	23383018	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	15.0	CHEMBL2558	Homo sapiens	% Control	%	15.0
Not Active	23383757	CHEMBL4887399	DAPK1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	100.0	CHEMBL2558	Homo sapiens	% Ctrl	%	100.0
Not Active	23384241	CHEMBL4887836	DAPK1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-3.29	CHEMBL2558	Homo sapiens	% inhibition	%	-3.29
Not Active	23384933	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	88.0	CHEMBL2558	Homo sapiens	% Control	%	88.0
Not Active	23385400	CHEMBL4879657	KinomeScan assay: inhibition of DAPK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	89.0	CHEMBL2558	Homo sapiens	% Control	%	89.0
